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Virological survey in stray carnivores and viral genetic characterisation
Free-roaming stray or feral dogs and cats living in urban areas can be responsible for the 
spread and maintenance of several infectious diseases. To investigate the presence of viral 
agents and the genomic diversity of canine and feline coronavirus (CCoV, FCoV) in Lisbon’s 
Municipal kennel, a virological survey was conducted which included canine distemper virus 
(CDV), canine and feline parvovirus (CPV,FPV), CCoV and FCoV, feline immunodeficiency 
virus (FIV) and feline leukaemia virus (FeLV). 
Blood samples and faecal swabs were collected from 50 dogs and 50 cats at the time of 
euthanasia, and 24 environmental swabs were collected at a later date. Samples were either 
tested  using a commercial ELISA kit,  or amplified by PCR and RT-PCR. All  coronavirus 
positive samples were further characterized by RT-PCR to assess the presence of different 
FCoV and CCoV genotypes. All PCR products were observed on 1,5%.agarose gel.
Antibodies against FIV were found in 18% of the samples, while FeLV antigen was found in 
10%. Viral nucleic acid was detected in 8.2% samples for CDV,  32.7% for CCoV, 59.6% for 
FPV/CPV, and 70% for  FCoV.  Seven (43.8%) samples were positive for  CCoV type I,  9 
(56.2%) for CCoV type II, and as for FCoV, 9 (25,7%), 6 (17%) and 12 (34.3%) samples were 
positive for FCoV type I, type II and both types, respectively. No differentiation was possible 
in 8 (23%) of the FCoV samples. There were positive environmental samples for CDV (50%), 
FPV/CPV (62.5%) and FCoV (87.5%).
The results found on this study, particularly on parvovirus and FCoV brought to our attention 
the need for a continued and more precise evaluation of the health status of free-roaming 
stray  or  feral  animals  in  the  municipal  kennel,  to  correctly  evaluate  their  role  as  viral 
reservoirs  within  and  without  the  kennel  premises.  The  high  prevalence  of  coronavirus 
infection found in both dogs and cats in the Lisbon Municipal Kennel allowed the viral genetic 
characterization,  showing  a  high  rate  of  co-infection  with  both  genotypes  of  FCoV and 
absence of co-infected animals with CCoV I and II. However, further investigation is needed 
in order to maintain a molecular epidemiological surveillance and help identify further CoV 
strains, as well as understand the pathogenic potential of these viruses.




Rastreio virológico de carnívoros errantes e caracterização genética viral
Os animais errantes ou assilvestrados que habitam áreas urbanas podem ser responsáveis 
pela  distribuição  e  manutenção  de  diversas  doenças  infecciosas.  Com  o  objectivo  de 
investigar  a presença de agentes virais  e avaliar  a  diversidade genética  de coronavirus 
canino  e  felino  (CCoV,  FCoV)  no  Canil  Municipal  de  Lisboa,  realizámos  um  rastreio 
virológico em que foram avaliados o vírus da esgana canina (CDV), parvovirus canino e 
felino (CPV,  FPV),  CCoV e FCoV,  o vírus da imunodeficiência felina  (FIV)  e o vírus da 
leucemia felina (FeLV).
Foram colhidas amostras de sangue e zaragatoas rectais de 50 cães e 50 gatos na altura da 
eutanásia,  e  24  zaragatoas  ambientais  numa  data  posterior.  Avaliámos  as  amostras 
utilizando um teste comercial de ELISA ou amplificando as amostras por PCR e RT-PCR. 
Todas as amostras positivas para coronavirus foram caracterizadas por RT-PCR para avaliar 
a presença de genótipos diferentes de FCoV e CCoV. Todos os produtos de PCR foram 
visualizados num gel de agarose a 1,5%.
Foram encontrados anticorpos contra FIV em 18% das amostras e antigénio de FeLV em 
10%. Detectámos ácido nucléico viral em 8.2% das amostras para CDV, 32.7% para CCoV, 
59.6% para FPV/CPV a 70% para FCoV. Sete (43.8%) amostras foram positivas para CCoV 
tipo I, 9 (56.2%) para CCoV tipo II, e em relação ao FCoV, 9 (25,7%), 6 (17%) e 12 (34.3%) 
amostras foram positivas para FCoV tipo I, tipo II, e para ambos os tipos, respectivamente. 
Não foi possível obter diferenciação em 8 (23%) das amostras para FCoV. Houve amostras 
ambientais positivas a CDV (50%), FPV/CPV (62.5%) e FCoV (87.5%).
Os resultados deste estudo demonstraram a importância de uma avaliação contínua e mais 
precisa  do estatuto  sanitário  dos  animais  errantes  ou assilvestrados no  canil  municipal, 
principalmente em relação ao parvovirus e ao FCoV, de modo a avaliar correctamente o seu 
papel de reservatórios de doenças, tanto dentro como fora do canil. A alta prevalência de 
infecções  por  coronavirus  em  cães  e  gatos  no  Canil  Municipal  de  Lisboa  permitiu  a 
caracterização genética viral, demonstrando uma percentagem elevada de co-infecções com 
os dois genótipos de FCoV, mas uma ausência de animais co-infectados com CCoV I e II. 
No entanto, é necessário mais investigação para manter uma vigilância epidemiológica ao 
nível  molecular,  de  forma  a  ajudar  na  identificação  de  possíveis  novas  estirpes  de 
coronavirus, assim como compreender o potencial patogénico destes vírus.
Palavras-chave:  rastreio  virológico,  epidemiologia  molecular,  vírus  de  animais  de 
companhia, coronavirus, FCoV, CCoV
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1. Introduction
The present study was part of the curricular training for the Integrated Masters in Veterinary 
Medicine from the Faculty of Veterinary Medicine (FMV), Universidade Técnica de Lisboa.  It 
consisted of a period of six months between 15th October 2008 and 15th April 2009 in the 
Virology and Molecular Biology Laboratory of the FMV under the supervision of Prof. Ana 
Isabel Pereira Duarte. During this time we conducted a virological survey of free-roaming 
carnivores at the municipal kennel in Lisbon, while participating in the diagnostic procedures 
at the virology laboratory. 
1.1 Laboratory work
The  Virology  and  Molecular  Biology  Laboratory  provides  diagnostic  services  for  several 
clinics, including the Teaching Hospital of the FMV and the Pathology Laboratory. Samples 
submitted  by  veterinary  clinicians  are  tested  for  different  viral  diseases  using  molecular 
biology or serological techniques. Among the different agents diagnosed in the laboratory, the 
most  common  are  feline  coronavirus  (FCoV),  feline  leukaemia  virus  (FeLV),  feline 
immunodeficiency virus (FIV) ,  feline/canine parvovirus (FPV/CPV) and canine distemper 
virus  (CDV).  Other  agents  are  tested  less  frequently,  like  feline  herpesvirus  (FHV),  and 
canine coronavirus (CCoV). 
Sample  materials  received  by  the  laboratory  include  whole  blood  (plasma/serum),  stool, 
intraperitoneal/intratoracic fluid and organ samples. Different materials are required and are 
processed accordingly to the agent to test for and the technique used (Table 1). FeLV and 
FIV are tested using serological techniques, namely an enzyme-linked immunosorbent assay 
(ELISA) for detection of Ag and Ab, respectively. Blood samples are previously centrifuged 
because the assay has better results with plasma/serum than whole blood. 
Table  1 -  Summary of  agents,  materials  and test  types performed at  the Virology and Molecular 
Biology Laboratory at the FMV
Agents Materials Test type
FeLV blood/plasma/serum Serological (ELISA)







Samples tested for other viruses use molecular biology techniques to assess the presence of 
viral  nucleic  acid,  by  polymerase  chain  reaction  (PCR)  for  DNA viruses  and  reverse 
transcriptase-PCR for RNA viruses. Liquid samples (blood, body fluids) are centrifuged and 
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the supernatant is processed for nucleic acid extraction using an appropriate commercial kit. 
Solid  samples  (stool,  organs)  are  homogenized  with  Phosphate  buffered  Saline  (PBS), 
centrifuged  and  processed  as  referred  for  liquid  samples.  A summary  of  the  samples 
analysed at the laboratory during the course of this study is presented in tables 2 and 3.
Table  2 - Number of samples analysed at the Virology and Molecular Biology Laboratory during the 











Table 3 - Number of samples of different biological materials received at the Virology and Molecular 






intraperitoneal/ intratoracic fluid 5
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1.2 Research project
Free-roaming stray or feral dogs and cats living in urban areas can be responsible for the 
spread and maintenance of several infectious diseases. These animals aren't confined or 
owned by anyone and both their number as well as their health status is mostly unknown to 
veterinarians and public health services. 
There is  a lot  of  information throughout  the scientific  literature about  virological  surveys. 
These  surveys  can  vary  greatly  in  terms  of  methodology  and  procedures,  can  be  very 
specific  or  very  general,  have  different  sample  sizes,  focus  on  several  or  only  one 
aetiological agent and some are conducted in collaboration with TNR programs (trap, neuter, 
release), usually oriented to control cat population. All of them help us gain greater insight 
into an existing disease or its agent and the way it interacts with its host. These surveys help 
us paint the picture of prevalence of disease in a population, but it is a picture which is never 
finished, because for every question we answer, new questions arise.. 
In this particular case, the original idea of a survey which would help us characterise the 
presence  of  specific  agents  in  the  environment  and  the  risk  to  both  wild  and  domestic 
animals, stumbled upon the difficult scenery of municipal kennels. Regulations conflict with 
compassion and the darkest  of  human nature as we try  to  understand the reasons why 
owners and citizens allow animals who share the same environment as them be relinquished 
to a kennel and ultimately euthanized after all other options are spent.  In the process, we 
came across problems with which our colleagues at the municipal kennel have had to deal 
for a long time. 
For  the  purpose  of  this  study,  “free-roaming”  describes  homeless  animals,  including 
socialized strays and unsocialized feral. In the case of the municipal kennel, most of the dogs 
were socialized, while practically all of the cats caught by the kennel employees were feral or 
barely socialized. 
The kennel is placed in the middle of the Monsanto Natural  Park,  yet  the facilities soon 
proved to be too small to contain the growing pet overpopulation in the Lisbon urban area, in 
spite of the abundant space surrounding it. Dogs are housed in three kennels: the main one 
(Figure 1-a) where most of the dogs are kept in open cells, alone, but with some contact with 
each others; another smaller room where aggressive animals are kept in containment cages 
(Figure 1-c); and an exterior kennel where more social dogs are housed in pairs, or in small 
groups (Figure 1-d). All cats are housed together with other animals captured in the same 
day, in a single room with a number of different cages (Figure 1-b). The same room also has 
cages for smaller dogs and young puppies. Cats considered fit for adoption, are also housed 
in groups in an exterior kennel. 
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Animals are delivered at any time of the day or night (when delivered by police forces), or 
captured by kennel employees and taken directly to one of the kennels after the entry record 
has  been  made.  Owners  who  relinquish  their  animals  sign  a  statement  and  provide 
identification. Veterinarians fill in details of the clinical examination and tend to any animals 
which require medical treatments. Although surgeries are performed, most of the treatments 
are supportive. When possible, animals are photographed to be advertised on the kennel 
website  for  adoption.  Euthanasia  is  usually  on  a  weekly  basis  for  the  simple  reason of 
keeping the kennel population at an acceptable number. During this study an average of 26 
animals per week were euthanized.
Among  the  problems  identified  at  the  beginning  of  the  study  by  the  veterinarians  and 
employees of the kennel were the lack of proper ventilation in the interior kennels, the high 
number of animals present at all times, which prevented any sanitary break from taking place 
and the difficulty in providing better health care to the animals who needed it, due to lack of 
financing support. 
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Figure 1 - Map of the municipal kennel highlighting the rooms sampled.
Main dog kennel (a); cat kennel (b); aggressive dogs kennel (c) and exterior kennel (d).
Both veterinarians and employees mentioned the presence of infectious diseases among the 
kennel  population,  specially  canine  distemper  and  parvovirus  among  the  dogs  and 
panleukopenia among the cats.
1.3 Objectives
In order to conduct a virological survey of both dogs and cats 100 samples were collected 
from animals  euthanized at  the  Lisbon municipal  kennel.  For  the  purpose of  this  study, 
canine distemper virus (CDV), canine parvovirus (CPV), canine coronavirus (CCoV), feline 
immunodeficiency virus (FIV), feline leukaemia virus (FeLV), feline coronavirus (FCoV), and 
feline  parvovirus  (FPV)  were  selected.  All  coronavirus  positive  samples  were  further 
characterized to assess the presence of  different  FCoV and CCoV genotypes within the 
animal population. 
Most of these animals were captured in urban areas in and around Lisbon and a few were 
delivered by their  owners to be euthanized for  health or other issues.  Since background 
information on the health status of these animals was lacking, antibody detection was only 
performed for FIV, because of its specific pathogenesis which produces persistent infection, 
but low level virus replication, and the fact that it has no commercial vaccine in Portugal. All 
other  viruses  were  tested for  the  presence of  antigen by  enzyme-linked  immunosorbent 
assay (ELISA) or nucleic acid by polymerase chain reaction (PCR).
This information was used to estimate the prevalence of these diseases in dogs and cats at 
the  Lisbon  Municipal  Kennel  and  evaluate  the  sanitary  conditions  in  the  kennel.  As  a 
secondary objective, we tried to estimate the role of stray and feral animals in the spread and 




Viruses from the family  Parvoviridae infect a wide variety of hosts, ranging from insects to 
primates (Hueffer  and Parrish,  2003).  The current  classification of  parvoviruses is based 
primarily on their host range and their dependence on help from other viruses for replication, 
traditionally  separating  them  into  autonomous  viruses  of  vertebrates,  helper-dependent 
viruses of vertebrates, and autonomous viruses of insects. Viruses from insects and other 
arthropods are included in the subfamily  Densovirinae,  while viruses from vertebrates are 
contained  in  the  subfamily  Parvovirinae (Lukashov  &  Goudsmit,  2001).  Among  these, 
members of the genus  Parvovirus are among the smallest DNA virus to include important 
pathogens of both dogs and cats (Patel & Heldens., 2009). The viruses are all classified as 
members of the feline parvovirus subgroup of the family Parvoviridae and are named for the 
host from which they are isolated—hence CPV, FPV, raccoon parvovirus, mink enteritis virus 
(MEV),  as  well  as  bluefox  parvovirus  (BFPV)  from  Arctic  foxes  (Parrish,  1995).  Feline 
panleukopenia virus (FPV) is considered the prototype parvovirus of carnivores (Truyen et 
al., 2009) and Canine parvovirus (CPV) is a host range variant which acquired the ability to 
infect dogs. While FPV infects all felids, as well as raccoons, minks and foxes, CPV infects 
members  of  the  Canidae family  and recently  regained  the  ability  to  infect  cats  (Truyen, 
Evermann, Vieler & Parrish, 1996). Current taxonomy defines canine parvovirus and feline 
panleukopenia virus as one single taxonomic entity (Tattersall, 2006 cited by Truyen et al., 
2009), but in the present study we refer to CPV as parvovirus in dogs and FPV parvovirus in 
cats.
6
Figure 2 - Parvovirus structure (a) and genome (b).
Adapted from http://www.expasy.ch/viralzone/.
Parvoriruses  are  small  and  spherical,  roughly  25  nm in  diameter,  without  an  envelope 
(Parrish, 1995) (Figure 2-a). FPV and CPV isolates may differ by as little as 0.5% in their 
DNA sequence (Hueffer et al., 2003). Their genome is a single-stranded DNA, roughly 5 kb 
long with hairpin structures at both ends and encodes two genes (Figure 2-b), which result in 
the expression of  two non-structural  proteins,  NS1 and NS2,  coded by  the  3'  end open 
reading frame. The capsid proteins are coded by an open reading frame towards the 5' end 
of the (negative sense) genomic DNA. The structural proteins VP1 and VP2 are formed by 
alternate splicing of the messenger RNA from the viral DNA, so that the complete sequence 
of  VP2  is  present  in  VP1  (Agbandje,  Parrish  and  Rossman,  1995;  Parrish,  1999).  The 
number of  capsid protein species per virion varies among parvoviruses.  There are three 
types of polypeptides in CPV, VP1, VP2 and VP3. VP3 is formed by cleavage of 15 to 20 
amino acids from the amino terminus of VP2 after virion assembly, and is not present in 
empty particles (Agbandje et al., 1995). The full capsid contains 60 copies of a combination 
of VP1, VP2 and VP3, with VP2 being the dominant protein (54-55 copies) (Parrish, 1999). 
The structure of the capsid defines three separate regions surrounding the threefold axes of 
symmetry,  termed  threefold  spike,  which  are  determinant  in  the  host  range  differences 
between CPV and FPV by allowing it to bind to different transferrin receptors in the host cell 
(Hueffer and Parrish, 2003). The carnivore group of parvoviruses shows high conservation of 
DNA sequences, with less than 1.3% sequence variation between diverse isolates collected 
30 years apart  (Truyen et  al.,  1995).  However,  several  sites in  VP2 of  CPV-2 display  a 
nucleotide substitution rate similar to that of RNA viruses, which caused them to undergo a 
complex  series  of  host  range  changes  in  the  past  three  decades,  and  determined  the 
appearance of diverse antigenic epitopes in naturally occuring variants of the virus (CPV-2a, 
2b, 2c),  (Truyen et al.,  1995; Truyen et al.,  1996;  Shackelton,  Parrish, Truyen & Holmes 
2005).
All  parvoviruses  are extremely  stable  and resistant  to  adverse environmental  influences, 
being able  to persist on inanimate objects for 5 months or longer (McCaw & Hoskins, 2006). 
FPV resists heating at 56º C for 30 minutes and most common detergents and disinfectants, 
such as 70% alcohol,  organic  iodines,  phenolics and quaternary ammonium compounds. 
One noteworthy exception is inactivation of both CPV and FPV by 6% sodium hypochlorite 
for 10 minutes at room temperature, which still has to be thorough, (Greene & Addie, 2006).
Feline panleukopenia virus (FPV) has been known to cause disease in cats, raccoons and 
some related carnivores for more than a hundred years (Lamm & Rezabek, 2008), while 
canine parvovirus (CPV) was first isolated in 1978 (Carmicheal & Binn, 19811). The new virus 
spread globally in a pandemic of disease during that same year and has since remained 
endemic in dogs throughout the world. There is no serological or other evidence for infection 
1 cited by Reed, Jones & Miller, 1988
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of dogs by a related virus prior to the mid-1970s (Parrish, 19902) and its exact evolution and 
origin remains elusive to date. One of the hypothesis about its sudden emergence suggested 
that CPV arose as a host range mutant directly from FPV in the dog or cat populations, 
similar to the scenario proposed for the emergence of MEV in the 1940s. Another hypothesis 
was that CPV emerged from a FPV vaccine virus after propagation in tissue culture and was 
initially spread in vaccine, which would explain the almost simultaneous appearance of CPV 
in  the  dog  populations  worldwide.  Various  isolates  from  wild  carnivores  support  the 
hypothesis that CPV arose in a different host  from the cat or dog, and that another carnivore 
may have harboured its immediate ancestor. DNA and amino acid analysis from one Arctic 
fox from Finland and red foxes from Germany revealed intermediate sequences between the 
FPV and CPV viruses, providing evidence of interspecies transmission between domestic 
and wild  carnivores  for  the first  time (Truyen,  Müller,  Heidrich,  Tackmann & Carmichael, 
1998; Truyen 1999). 
Since the emergence of CPV it has continued to grow at an exponential rate, contrary to 
FPV, which maintains a population growth rate compatible with its endemic nature.  CPV 
growth is characteristic of an epidemic, as it adapted to its canine host in a matter of years, 
spread across the world in a couple of months and subsequently generated a number of 
antigenic and host-range variants (Shackelton et al., 2005). CPV-2 was replaced by CPV-2a 
in 1981 and again by CPV-2b between 1984 and 1990 (Patel & Heldens, 2009). Interestingly, 
these variants show only a few amino acid substitutions in its genomic sequence. According 
to Truyen (2006) the adaptation to a new host was most likely due to the virus gaining the 
ability to bind the canine transferrin receptor, which is used to enter and infect canine cells. A 
new strain, emerged in the end of the 1990s,  was characterised by a mutation in a major 
antigenic  site  of  the  viral  capsid  (position  426  Asp  to  Glu)  and  was  named  CPV-2c 
(Buonavoglia et al., 2001; Decaro et al., 2007a). This strain has already spread worldwide, 
yet it is still more prevalent in Europe (Nakamura et al., 2004; Decaro et al., 2007a; Hong et 
al.,  2007; Kapil et al., 2007; Peréz et al.,  2007). While the virulence and pathogenicity of 
CPV-2c were first deemed to be low, more recent reports are conflicting (Decaro et al., 2005; 
Decaro et al., 2008), just like reports on the efficacy of current vaccines (Decaro et al., 2008; 
Spibey, Greenwood, Sutton, Chalmers & Tarpey, 2008; Calderon et al., 2009).
Both CPV and FPV are highly contagious and most infections are a result of contact with 
contaminated faeces, but also fomites, insects and rodents. Animals may carry the virus in 
their hair coat for extended periods (McCaw & Hoskins, 2006). Infection in domestic dogs 
doesn't always result in apparent disease, as many dogs which are naturally infected never 
develop overt clinical signs (McCaw & Hoskins, 2006). Clinical illness is usually most severe 
in young puppies, especially when they harbour other pathogens such as parasites or enteric 
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bacteria. Incubation periods can vary between 7-14 days for CPV-2 and as brief as 4-6 days 
for newer variants (McCaw & Hoskins, 2006) and infected carnivores shed virus at high titres 
in their faeces (Truyen et al., 2009). 
The pathogenesis of parvovirus infections is influenced primarily by the requirement of DNA 
replication  for  mitotic  cells.  Following  oronasal  exposure,  the  virus  first  replicates  in  the 
mucosa and lymphoid tissue of the buccal cavity and spreads next via cell-free viraemia to 
other internal organs. In vivo tissue tropism of FPV and CPV varies, but after progeny virus 
spread it  can be found in virtually all organ tissues in both dogs and cats (Decaro et al., 
2007c; Truyen et al., 2009). In puppies secondary sites of infection are typically the liver and 
heart,  and  animals  often  succumb  to  heart  failure  associated  with  pulmonary  oedema, 
hepatomegaly  and  ascites.  Older  dogs  commonly  present  with  vomiting,  diarrhoea  and 
leucopoenia with a high morbidity, but a much lower mortality than in puppies. The disease 
induced by the Glu-426 mutant CPV-2c has been described as mild in pups, with mucoid 
diarrhoea  and  relative  leucopoenia  and  lymphopenia  (Decaro  et  al.,  2005),  but  a  more 
severe clinical course with higher mortality rates was also described in a breeding kennel in 
Italy (Decaro et al., 2008).
Pathogenesis of FPV infection in cats is similar and the infection is systemic. Replication 
causes shortening of  the intestinal  villi  due to a sometimes complete loss of  the rapidly 
dividing epithelial cells in the gut. Thus, the most common clinical sign is diarrhoea followed 
by leucopoenia and anaemia caused by replication of the virus in early progenitor cells of the 
bone marrow. Kittens infected during pregnancy may present cerebellar ataxia and intention 
tremor due to impaired development of the cerebellum caused by lytic virus replication in the 
Purkinje cells (Truyen et al., 2009).
The clinical diagnosis of CPV-2 infection is indecisive, since several other pathogens may 
cause diarrhoea in dogs. Several methods are available for the laboratory diagnosis of CPV 
infections.  Virus  isolation from blood or  faeces in  cell  cultures and the demonstration of 
haemagglutination of  porcine erythrocytes have been extensively  used for  diagnosis,  but 
these methods are too labour-intensive and time-consuming for routine diagnostic testing 
(Desario et al.,  2005). In practice, antigen detection in faeces is usually carried out using 
commercially available latex agglutination or immunochromatographic tests (Truyen et al., 
2009), and recent advances in molecular technique have led to the development of highly 
sensitive and specific PCR and real-time PCR assays for the detection and quantisation of 
CPV-2 DNA in the faeces of diarrhoeic dogs (Desario et al., 2005). However, the period of 
faecal viral shedding is brief and virus is seldom detected by 10 to 12 days after natural 
infection.  Furthermore,  vaccine  virus  can  yield  false-positive  results  up  to  12  days  after 
vaccination (McCaw & Hoskins, 2006). On the other hand, the use of an antibody test such 
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as ELISA or indirect immunofluorescence is of limited value, because serological tests do not 
differentiate between infection and vaccination induced antibodies (Truyen et al., 2009).
Both CPV and FPV vaccines are considered core vaccines by the Vaccinations Guidelines 
Group  (VGG) of  the  World  Small  Animal  Veterinary  Association  (WSAVA).  Modified  live 
vaccines have been available for some time and are recommended because of the more 
rapid and effective immunity they produce in comparison to inactivated virus vaccines. These 
are only recommended in the case of pregnant queens and kittens younger than 4 weeks, 
because no  danger  exists  of  post-vaccinal  virus  spread  or  clinical  illness  as  a  result  of 
reversion to virulence (Greene & Addie, 2006; Day, Horzinek & Schultz, 2007). The recent 
emergence  of  CPV  variants  which  infect  even  animals  which  have  been  repeatedly 
vaccinated has raised concerns that the antigenic differences between the original type 2 
and its variants may decrease the effectiveness of the CPV-2 based vaccines and it would be 
useful  to  prepare vaccines using the CPV variants circulating in  the field  (Decaro et  al., 
2008).
1.5 RNA Virus
1.5.1 Canine Distemper Virus
Canine  distemper  (CD)  is  considered  by  many  the  most  important  worldwide  infectious 
disease  of  domestic  dogs,  and  its  fatality  rate  is  second  only  to  that  of  rabies.  This 
morbillivirus infection of dogs and other carnivores, has been recognized for at least 250 
years and the first report of CD was from South America by Ulloa in 1746. Heusinger was 
convinced that the disease was introduced in 1760 from Peru to Spain, from where it spread 
to other parts of Europe and Russia within a few years. The epidemic spread of CD through 
Europe  started  around  the  1760s,  but  the  disease  may  have  occurred  earlier  and  was 
possibly  confused  with  rabies.  In  1815  Jenner  observed  that  CD  among  dogs  is  as 
contagious as smallpox, measles and scarlet fever among humans and Karle succeeded in 
experimentally transmitting CD in 1844, by brushing the lips of young dogs with discharge 
from diseased dogs. The aetiology of the disease remained controversial until 1905, when 
Henri Carré demonstrated it was caused by a filterable virus (Carré, 19053; Blancou, 2004). 
Clinical distemper has been largely controlled by routine vaccination in domestic dogs since 
the 1950s, but evidence of vaccinal failure caused by the emergence of viral variants in the 
recent  years  has  raised  concerns  and  renewed  investigation  efforts.  Vaccine-induced 
infections have occurred in a variety of species, as have large-scale epidemics in felids and 
CDV may have the most far reaching implications of any infectious agent for susceptible 
free-living and captive carnivores. The discoveries of related viruses, such as phocine and 
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delphine morbilliviruses, and CDV’s similarity to the measles virus suggest viral mutability 
and a zoonotic potential for CDV (Deem, Spelman, Yates & Montali, 2000).
The  genus  morbillivirus  within  the  family  Paramyxoviridae  includes  important,  highly 
contagious pathogens of animals and man. Until recently the genus comprised four distinct 
members: measles virus (MV) of man, canine distemper virus (CDV) of canines and their 
relatives, rinderpest virus (RPV) of cloven-hoofed animals, and peste-des-petits-ruminants 
virus (PPRV) mainly  of  small  ruminants.  All  of  these may cause severe disease in  their 
respective host and MV is considered the prototype virus for the genus. Knowledge of the 
natural  host  range  is  a  major  factor  in  differentiating  between  these  closely  related 
morbillivirus species (Blixenkrone-Möller et al., 1992), and the natural host range for CDV 
has recently been proven to comprise all families of the order Carnivora (Deem et al., 2000).
CDV has a variable diameter between 150-250 nm, with negative-sense,  single-stranded 
RNA, containing six non-overlaping genes encoding six structural proteins and enclosed in a 
nucleocapsid of helical symmetry (Greene & Appel, 2006) (Figure 3). It is surrounded by a 
11
Figure 3 - Structure of canine distemper virus (a) and its genome (b).
N – nucleocapsid protein;  P – phosphoprotein;  C, V – transcriptional units;  M – matrix protein;  F – 
fusion protein; H – hemagglutinin; L – large protein. Adapted from http://www.expasy.ch/viralzone/.
lipoprotein envelope derived from the host cell membrane, where the virus incorporates the 
matrix protein (M) and two glycoprotein spikes, the hemagglutinin (H) and fusion protein (F). 
The nucleocapsid protein (N) encapsulates and protects the RNA and is associated with the 
phosphoprotein (P) and the large protein (L) which assists in transcription and replication 
(Blixenkrone-Möller  et  al.,  1992;  Barrett,  1999;  Martella,  Elia  & Buonavoglia,  2008).  Two 
additional proteins, C and V, are found as transcriptional units within the P gene (Beineke, 
Puff, Seehusen & Baumgärtner, 2009). The viral protein M is responsible for connecting the 
nucleocapsid and the surface glycoproteins H and F during viral maturation (Beineke et al., 
2009), while the H protein is responsible for attachment to cell receptors and the F protein 
promotes fusion of the cell membrane with the viral envelope, and also between host cells 
(Martella et al., 2008). While CDV is considered to have one antigenic type, CDV strains can 
be divided into distinct lineages, based on phylogenetic analysis of subgenomic F, P, and 
complete H gene sequences, which are mainly associated with the geographical area from 
which the strain is isolated (Lednicky et al., 2004, Lan et al., 2005, Martella et al., 2006).
CDV is extremely susceptible to heat and drying and is destroyed by temperatures greater 
than 50º C for 30 minutes. It may survive in excised tissues and secretions for up to 3 hours, 
but does not usually persist in kennels after infected dogs have been removed, especially in 
warm climates.  The virus  remains  viable  between pH 4.5  and 9.0  and is  inactivated by 
ultraviolet  light.  As  an  enveloped  virus,  it  is  susceptible  to  ether  and  chloroform,  dilute 
formalin  solution,  phenol  and  quaternary  ammonium  disinfectant.  Routine  disinfection 
procedures  are  usually  effective  in  destroying  the  virus  in  kennel,  clinic  or  hospital 
environments (Greene & Appel, 2006).
Transmission occurs mainly by direct animal-to-animal contact and the virus can be detected 
from most body tissues, including urine (Elia et al., 2006; Greene & Appel, 2006) However, it 
is most abundant in respiratory exudates and commonly spread by exposure to infectious 
aerosol or droplets (Green and Appel, 2006). Viral shedding occurs by 7 days postinfection 
and  can  last   60  to  90  days,  although  shorter  periods  are  more  typical.  Transplacental 
infection can occur and the virus is maintained in a population by contact among infected 
animals and a constant supply of susceptible puppies for infection. Although immunity after 
exposure to the wild-type virus is prolonged or life-long, it is not as absolute after vaccination 
and there are estimates that 25-75% of susceptible animals become subclinically infected, 
but clear the virus. However, some dogs aren't able to clear the virus completely and may 
harbour  it  in  their  central  nervous system.  Spontaneous distemper  is  correlated in  most 
cases with the loss of maternal antibodies, affecting dogs between 3 and 6 months the most, 
but  disease  can  be  severe  and  widespread,  affecting  all  ages,  in  susceptible  isolated 
populations  and  different  strains  may  have  different  pathogenicity  and  clinical  evolution 
(Green and Appel, 2006).
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Great variations in duration, severity and clinical presentation of distemper have been found 
in experimentally infected dogs as well as in animals suffering from natural disease. The 
incubation period may vary from 1 to 4 weeks and depends on viral strain, age of the animal 
at the time of infection and immune status of the host. Disease manifestation ranges from 
virtually  no  clinical  signs  to  severe  disease  with  approximately  50%  mortality.  Tissue 
macrophages  and  monocytes  located  in  or  along  the  respiratory  epithelium  and  tonsils 
represent  the first  cell  type to pick up and propagate the virus after natural  exposure by 
aerosol  droplets.  Following  this  local  burst  of  virus  replication  the  pathogen  is  then 
disseminated  by  lymphatics  and  blood  to  distant  hematopoietic  tissues  during  the  first 
viraemic phase  (Beineke et al., 2009). The virus multiplies from 4-6 days PI in the lymphoid 
follicles of the spleen, in the lamina propria of the stomach and small intestine, and in the 
Kupffer’s cells in the liver,  which is accompanied by an initial  fever 3-6 days PI.  Further 
spread of CDV to epithelial and central nervous system (CNS) tissues 8-9 days PI depends 
on the immune status of the dog, and most likely takes place both as a cell-associated and 
plasma-phase  viraemia  (Green  and  Appel,  2006).  The  clinical  picture  in  all  susceptible 
species manifests most frequently in respiratory, gastro-intestinal, integumentary, and CNS 
systemic signs, which may emerge several months later, and without any preceding systemic 
signs. Biphasic fever and general malaise are often associated with viraemia (Deem et al., 
2000).
Practical diagnosis of canine distemper is primarily based on clinical suspicion, but there are 
a number of specific confirmatory laboratory tests available which detect either CDV or a 
specific  immune  response  in  samples  from  the  affected  animal.  Virus  isolation  is  still 
considered the gold standard, but it's not straight forward since it requires that virulent CDV 
is adapted before it grows in routinely-used epithelial or fibroblast cell lines. The best results 
are achieved by direct cultivation of buffy coat cells or other target tissues from the infected 
host together with mitogen-stimulated dog lymphocytes (Greene & Appel 2006). RT-PCR can 
demonstrate CDV from buffy coat cells of dogs with acute infection and from serum, whole 
blood, cerebrospinal fluid (CSF) or urine of dogs with systemic or neurological CD (Shin et 
al.,  1995; Frisk, Konig, Moritz & Baumgartner,  1999,  Saito et al.,  2006).  RT-PCR can be 
applied  for  the  detection  of  CDV  from  smears  of  epithelial  cells  and  from  other  tissue 
samples. A positive RT-PCR result is indicative of CD infection, whereas a negative one can 
result from various reasons. Other confirmatory test available for antemortem diagnostic are 
immunofluorescence assays,  ELISA and immunohistochemistry performed on blood,  CSF 
and tissue samples (Greene & Appel 2006).
The first  vaccine against CD was made in 1923 by Puntoni from the formalin-inactivated 
brain tissue of a dog suffering from CD encephalitis (Appel, 19994). The protection obtained 
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with  inactivated  vaccines  was  limited,  and  they  are  no  longer  used.  However,  active 
immunization was not successful before MLVs became available in the 1950s. All commercial 
CD vaccines available for dogs are multivalent vaccines and are considered core vaccines 
for both domestic dogs and animals in shelter environments (Day et al., 2007). Vaccinal virus 
is shed by animals for a little over a week after vaccination (Kim, Cho, Youn, Yoo & Han, 
2001).  Not  all  vaccine  produce  the  same  level  of  protection  and  increased  potency  of 
protection is often associated with induced illness, especially in wild or immunocompromised 
domestic carnivores (Greene & Appel 2006). 
1.5.2 Coronavirus
This virus genus belongs to the family Coronaviridae, within the order Nidovirales and can be 
grouped into three clusters, as defined by their antigenic and genomic properties (Addie et 
al.,  2009).  Of  interest  to  this  study,  feline  coronavirus  (FCoV)  and  canine  coronavirus 
(CCoV), belong to subgroup 1a coronaviruses (Addie et al., 2009; Decaro and Buonavoglia, 
2008; Pratelli et al., 2002; Lorusso et al., 2008), together with transmissible gastroenteritis 
virus  (TGEV)  of  swine,  porcine  respiratory  coronavirus  (PRCoV)  and  porcine  epidemic 
diarrhoea virus (PEDV). Group 2 is subdivided into groups 2a and 2b, depending whether 
they are bovine-like coronaviruses or severe acute respiratory syndrome (SARS)-like. The 
recent canine respiratory coronavirus (CRCoV) is included in the latter. The third coronavirus 
(CoV) group comprises CoVs of avian origin, such as the avian bronchitis virus.
Coronaviruses are the largest RNA viruses known thus far (Gorbalenya, Enjuanes, Ziebuhr & 
Snijder, 2006), with genome sizes ranging between 27 and 31 kb. They are roughly spherical 
enveloped viruses 100-200 nm in diameter, with a fringe of circa 20 nm long petal-shaped 
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Figure 4 - Coronavirus structure (a) and comparison of CCoV and FCoV genome (b).
S – spike protein;  E – envelope protein;  M – membrane protein;  N – nucleocapsid protein;  RNA – 
genomic  RNA.  Virion  structure  dapted  from  http://www.expasy.ch/viralzone/.  Genome  structure 
adapted from Decaro and Buonavoglia, 2008.
spikes with single-stranded positive sense RNA (Figure 4) and different CoVs have a  similar 
genome organization, with a set of five genes in conserved order (de Vries, Horzinek, Rottier 
&  de  Groot,  1997).  More  than  70%  of  the  genome  in  the  5'  end  is  taken  up  by  two 
overlapping open reading frames (ORFs) encoding two replicase polyproteins from which up 
to 16 mature products are derived. These proteins are required for RNA synthesis and other 
aspects  of  viral  replication  (de  Vries  et  al.,  1997;  Lorusso  et  al.,  2008).  Four  structural 
proteins are encoded by genes in a 3'-coterminal nested set of subgenomic mRNAs, namely 
the spike, envelope, membrane and nucleocapsid proteins (de Vries et al., 1997). The spike 
(S) protein forms the characteristic viral peplomers which mediate viral attachment to specific 
cell receptors and fusion between the envelope and the plasma membrane (Enjuanes et al., 
20005).  The  envelope  protein  (E)  is  an  integral  membrane  protein  and  thought  to  be 
important for viral envelope assembling (Vennema et al., 1996). The membrane protein (M), 
a type III glycoprotein, is the most abundant structural protein. The nucleocapsid protein (N) 
is  a highly  basic  phosphoprotein which modulates viral  RNA synthesis,  binding to it  and 
forming a helical nucleocapsid. In addition to these structural proteins, CoVs may have a 
varying number of ORFs encoding non-structural proteins also expressed from subgenomic 
mRNAs (Lorusso et al., 2008). Most of these proteins aren't essential for replication and their 
exact function is unknown, but may be connected to virulence and host range (Yamanaka, 
Crisp, Brown & Dale, 1998; Haijema, Volders & Rottier, 2004).
CoVs lose infectivity after approximately 40 hours at room temperature or 60 hours when 
refrigerated (Tennant, Gaskell & Gaskell, 1994), but virus has been shown to survive outside 
cats for up to 7 weeks in dry conditions (Addie and Jarret, 2006). They are readily inactivated 
by most commercial detergents and disinfectants (McCaw & Hoskins, 2006). 
Coronaviruses are important pathogens of mammals and birds. Clinical signs are usually 
enteric or respiratory, but can also be systemic. Feline infectious peritonitis (FIP) was first 
described as an important disorder of cats in 1963, and though the disease was thought to 
be  infectious,  no  specific  aetiologic  agent  was  identified  until  1970,  when  the  close 
similarities  of  FIP  virus  (FIPV)  in  tissues  to  members  of  the  family  Coronaviridae was 
recognized. The close genetic relationship of FIPV to coronaviruses of dogs and swine was 
first  reported  by  Pedersen  et  al.  in  1978  and  the  existence  of  two  serotypes,  feline 
coronavirus (FCoV)-like and canine coronavirus (CCoV)-like, of feline coronaviruses was first 
reported in 1984. The incidence of the disease increased  in the 1960s onward, and it is 
currently one of the leading infectious causes of death among young cats from shelters and 
catteries. The reason for its sudden emergence is not known, but some suggest the virus 
may have speciated into cats within the last half century. TGEV was first described in North 
America a decade earlier and at least one strain of CCoV can induce mild enteritis in cats 
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and  enhance  a  subsequent  infection  with  FIPV  (Pedersen,  Allen  &  Lyons,  2008). 
Recombinants between these three viruses are known to occur, favoured by the ease with 
which transcription  units  (RNAs)  can be gained or  lost  during  the divergent  evolution  of 
coronaviruses. (de Groot, Ter Haar, Horzinek & Van Der Zeijst, 1987). Another hypothesis 
suggests that  the FIP mutation may be selective to a variant FCoV that appeared in the 
1950s,  which  could  have  arisen  because  of  the  intra-  and  inter-species  mutability  of 
coronaviruses (Pedersen et al., 2008).
The  first  report  on  CCoV  infection  is  dated  1971,  when  the  virus  was  first  isolated  a 
coronavirus from faeces of dogs with suspected infectious enteritis in a canine military unit in 
Germany  (McCaw  &  Hoskins,  2006).  Since  then,  several  CCoV  outbreaks  have  been 
reported worldwide, although its true importance as a cause of infectious enteritis in the dog 
population is still unknown. Serological and virological investigations have demonstrated that 
CCoV is widespread in dog population, mainly in kennels and animal shelters (Decaro and 
Buonavoglia, 2008) and serological evidence suggest CCoV has been present indefinitely in 
the dog population and is  an infrequent  cause of  infectious enteritis  (McCaw & Hoskins, 
2006).
Feline coronavirus may be subdivided serologically and by nucleotide sequencing into two 
types. Type I virus is the most prevalent (Hohdatsu, Okada, Ishizuka, Yamada & Koyama, 
1992;  Addie,  Schaap,  Nicolson,  & Jarrett,  2003; Vennema, 1999;  Kummrow et  al.,  2005; 
Shiba, Maeda, Kato, Mochizuki & Iwata, 2007). Type II virus is less common, resulting from 
recombination between type I feline coronavirus and canine coronavirus involving the spike 
gene  (Herrewegh,  Smeenk,  Horzinek,  Rottier  &  de  Groot,  1998),  and  can  be  readily 
propagated in cell cultures, unlike type I virus (Pedersen et al., 1984). Both types of virus can 
induce  FIP  and  feline  coronavirus  strains  have  also  been  subdivided  into  two  distinct 
“biotypes”: Feline Enteric Coronavirus (FECV) and Feline Infectious Peritonitis Virus (FIPV). 
Technically,  FCoV includes all strains (numerous), serotypes (types I and II) and biotypes 
(enteric or infectious peritonitis viruses) of the genus (Pedersen et al., 2008), but since all 
FCoV may induce systemic infection, such descriptions are perhaps best avoided (Addie et 
al., 2009).
Genetic  analysis  of  several  CCoVs  detected  in  pups  with  diarrhoea  in  Italy  revealed  a 
number of point mutations affecting a fragment of the M gene, which led to the designation of 
these  atypical  CCoVs  as  FCoV-like  CCoVs  (Pratelli  et  al.,  2002).  Phylogenetic  analysis 
showed that this new strain segregates with FCoVs type I rather than reference CCoVs and 
FCoVs type II and it has since been designated as the prototype of the newly recognised 
CCoV type I, whereas reference CCoVs have been referred to as CCoV type II. Unlike group 
1 CoVs, CCoV type I shares with members of groups 2 and 3 a potential cleavage site in the 
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S protein, although the potential implications in viral pathobiology have not been determined 
(Pratelli et al., 2003a).
Coronaviruses  are  highly  contagious  and  spread  rapidly  through  groups  of  susceptible 
animals.  Faeces are the major  source of  both FCoV and CCoV and the major  mode of 
transmission is  believed to be the faecal-oral  route,  though contamination via saliva and 
transplacental  transmission have been described.  Susceptible  cats  are  most  likely  to  be 
infected with FCoV from asymptomatic cats and litter boxes represent the main source of 
infection in groups of cats (Addie et al., 2009).  Following natural infection with FCoV cats 
begin to shed virus in the faeces within one week (Pedersen, Sato, Foley & Poland, 2004) 
and shedding continues for weeks to months, while a small proportion of carrier cats may 
shed virus for life (Addie et al., 2009). Young animals are at greater risk of developing clinical 
disease and FIP (Hartmann 2005; McCaw & Hoskins, 2006). Dogs shed the virus starting at 
1 to 4 days post-infection and it  can be isolated in faeces of infected dogs for weeks to 
months (Tennant et al., 1994; McCaw & Hoskins, 2006; Decaro and Buonavoglia, 2008).
Most  FCoV infections proceed asymptomatically or only with minor signs of enteritis,  but 
about 12% of infected cats (Addie et al., 2003), 70% of them less than a year old (Hartmann, 
2005), develop a lethal systemic pyogranulomatous disease called FIP (Addie et al., 2009). 
Its precise cause is still unclear, but could either be a mutation favouring viral replication in 
monocytes and macrophages (Haijema et al., 2004; Rottier, Nakamura, Schellen, Volders & 
Haijema, 2005; Cornelissen, Dewerchin, Van Hamme & Nauwynck, 2007), or the interaction 
between viral load and the cat’s immune response (Meli et al., 2004; Dewerchin, Cornelissen 
& Nauwynck, 2005; Rottier et al., 2005; Kipar et al., 2006; Dye & Siddell, 2007) and it is likely 
that both viral genetics and host immunity play a role in the development of FIP. The two 
forms of the disease described are called “wet”, or effusive, and “dry”, or non-effusive, and 
whether a cat develops the wet or dry form is thought to depend on strength of the T-cell-
mediated immune response, which is probably the only efficient immune response against 
disease  progression  (Cornelissen  et  al.,  2007).  While  virus  replicates  to  high  titres  in 
monocytes and can be found in many organs in cats with FIP, it is mainly confined to the 
intestine in asymptomatic cats, even though a low-level monocyte-associated viraemia can 
still be detected by RT-PCR (Herrewegh et al., 1995; Meli et al., 2004; Addie et al., 2009). 
Activation  of  monocytes and perivascular  macrophages may lead to the development  of 
typical widespread pyogranulomatous and vasculitis/perivasculitis lesions in various tissues 
and organs, including lung, liver, spleen, omentum, and brain of cats with FIP (Addie et al., 
2009).
CCoV infections are usually also restricted to the alimentary tract, leading to the onset of 
clinical signs typical of the gastroenteric involvement including loss of appetite, vomiting, fluid 
diarrhoea,  dehydration  and,  only  occasionally,  death.  Usually,  systemic  disease  is  not 
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observed during CCoV infection, although the virus has been isolated from several tissues 
(tonsils, lungs and liver) of pups infected experimentally (Tennant, Gaskell, Kelly, Carter & 
Gaskell,  1991)  and a highly virulent  strain has been reported in  Italy,  where it  caused a 
systemic disease followed by a fatal outcome in pups (Buonavoglia et al., 2006; Decaro et 
al.,  2007b).  Clinical  signs  consisted  of  fever,  lethargy,  loss  of  appetite,  vomiting, 
haemorrhagic  diarrhoea,  severe  leucopoenia  and  neurological  signs  (ataxia,  seizures) 
followed by death within 2 days after the onset of the symptoms. Fatal disease commonly 
occurs  as  a  consequence  of  mixed  infections  with  CCoV  together  with  CPV-2,  canine 
adenovirus type 1 or CDV (Decaro and Buonavoglia, 2008).
Diagnosis  of  these diseases was difficult  before  the  development  of  sensitive  molecular 
techniques and diagnosis of FIP intra vitam is still extremely challenging in the absence of 
effusion (McCaw & Hoskins, 2006; Addie et al., 2009). Coronavirus particles can be observed 
in electron microscopy,  but false-negatives are possible.  The original  virus strains do not 
grow well  in tissue or cell  culture systems, which renders virus isolation difficult.  Positive 
serum titres detected by ELISA or serum neutralization only confirm exposure to the viruses, 
though the presence of IgM antibodies against CCoV is indicative of recent infection (Naylor, 
Monckton,  Lehrbach & Deane,  2001;  McCaw & Hoskins,  2006).  Viral  detection in  blood, 
faeces, or effusions using highly sensitive RT-PCR assays are becoming more common, 
though the test is not a useful prognostic indicator for the development of FIP, and false-
negatives in FIP-positive cats are possible (Hartmann et al., 2003; McCaw & Hoskins, 2006; 
Addie et al., 2009). 
CCoV vaccination is not recommended at the moment due to the questionable efficiency of 
available vaccines and the frequency of adverse reactions (Pratelli et al., 2004a). Vaccine 
development has been especially aimed at preventing FIP, but the phenomenon of antibody-
dependent enhancement has foiled many attempts so far,  because cats with pre-existing 
antibodies, especially those directed against the spike protein, developed an enhanced form 
of disease in experimental infections, typified by an earlier development and a shortened 
disease course leading to a more rapid death (Addie et al., 2009). However, the role of ADE 
in natural infection is not clear since in field studies cats were most likely to develop FIP on 
first exposure to FCoV (Addie et al., 2003). There is one commercial vaccine available for 
cats which contains a temperature sensitive mutant of the type 2 FCoV and is designed to be 
administered  intranasally,  thus  inducing  local  mucosal  immune  responses  through  the 
induction of IgA and cell mediated immunity. Unfortunately there is considerable controversy 
regarding the efficacy and safety of this vaccine (Addie et al., 2009). Recent efforts oriented 
towards the development of a vaccine which protects by cellular mediated immunity have 
been successful in creating a live attenuated vaccine by deletion of genes implicated in viral 
virulence which is ready to be tested in the field and prepared for the market if successful, 
18
even if  no  explanation  for  this  success  has  been found (Haijema,  Schellen,  Egberink  & 
Rottier, 2009).
1.5.3 Retroviruses
Among  the  three  genera  to  cause  common  infection  in  pets,   feline  foamy  virus  is  a 
transmissible retrovirus considered non-pathogenic, but feline leukaemia virus (FeLV) and 
feline immunodeficiency virus (FIV) can cause a variety of life-threatening conditions in both 
domestic as well as wild felines, unless properly managed (Levy et al., 2008b). Dogs, on the 
contrary,  have  no  well-characterized  retroviral  infections,  in  spite  of  periodic  reports 
compatible with this type of infections (Dunham & Graham, 2008). Additionally in the cat, a 
number  of  endogenous,  nonpathogenic  retroviruses  (enFeLV and  RD-114)  are  reported, 
derived  from ancient  retroviral  infections  of  their  ancestors,  which  cannot  be  induced  to 
produce  infectious  virus  particles  and  are  inherited  by  transmission  through  germ  line. 
Retroviruses  are  enveloped  viruses  with  single-stranded  RNA genome which  is  reverse 
transcribed  by a specialized enzyme into dsDNA and integrated into the host cell genome. 
The  virus  depends  on  the  enzymatic  machinery  of  the  host  cell  for  replication  and  so 
infection doesn't normally lead to cell death (Lutz et al., 2009). 
Feline  leukaemia  virus  was  first  described  in  1964  when  virus  particles  were  observed 
budding from the membrane of malignant lymphoblasts from a cat with naturally occurring 
lymphoma. The virus was proven to be capable of transmiting lymphocytic neoplasia when 
experimentally injected into healthy cats and was thought to account for most disease-related 
deaths in pet cats for many years (Hartmann 2006). The isolation of a T-lymphotropic virus 
possessing the characteristics of a lentivirus from pet cats in Davis, California was reported 
in 1987 and it was evident that in causing an acquired immunodeficiency syndrome in cats, 
FIV was of substantial veterinary importance. The virus has remained the object of intense 
investigation as a model of lentiviral pathogenesis and prevention (Hartmann, 1998; Sellon & 
Hartmann, 2006). Both are among the most common infectious diseases of cats (Levy et al., 
2008b).
FeLV is a  γ-retrovirus of the subfamily  Orthoretrovirinae typically associated with the long-
latency induction of leukaemia and lymphoma in cats. It  occurs in nature not as a single 
genomic species, but as genetically complex families of closely related viruses (Levy, 2008). 
FIV is  part  of  the same subfamily  as FeLV,  Orthoretrovirinae,  but  belongs to the  genus 
Lentivirus, which shares many properties with human immunodeficiency virus (HIV). For this 
reason it has become a model of lentiviral pathogenesis and prevention and remains until 
today the object of intense investigation (Sellon & Hartmann, 2006). 
The diameter of FeLV virus is ~127 nm (DeBlois & Wesley, 1977) and the extracellular virion 
shows no symmetry of the nucleocapsid (Sarkar, Nowinski & Moore, 1971). Its genome is 
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similar to other retroviruses in the family (Figure 5-a). The single-stranded RNA transcribed 
into  a  ~8.5kb  dsDNA (Soe,  Devi,  Mullins  &  Roy-Burman,  1983)  by  the  viral  reverse 
transcriptase (RT) is called provirus, and is integrated into the host cell genome. The gene 
sequence includes the group specific antigen group gene (gag), the polymerase gene (pol) 
and the envelope gene (env). These genes are flanked on both sides by long terminal repeat 
sequences  (LTRs),  with  a  regulatory  function  of  the  viral  expression  and  replication 
(Hartmann, 2006). The complete FIV virion is spherical to ellipsoid in shape, 105-125 nm in 
diameter with short, poorly defined envelope projections (Pedersen et al., 19876). Each virion 
contains two copies of the positive-sense, polyadenylated RNA genome and a number of 
molecules of viral proteins (Bendinelli et al., 1995). Its genome organization is similar to other 
retro viruses and lentiviruses, with ~9400 base pairs (Hartmann, 1998) and additional ORFs 
encoding  accessory  proteins  allowing  the  virus  to  regulate  its  life  cycle  more  tightly  or 
productively (Dunham & Graham, 2008) (Figure 5-b).  The  gag gene codes internal virion 
proteins, such as the matrix, capsid and  nucleocapsid protein. The capsid protein p27 of 
FeLV and p24 of FIV are both important for diagnosis purposes (Hosie et al., 2009) and p27 
is produced in infected cells abundantly, which means it can be detected in the cytoplasm of 
infected cells,  as well as in the plasma of infected cats (Hartmann, 2006).  The  pol gene 
codes  the  viral  enzymatic  proteins  namely,  the  protease  determinant  for  the  virion 
maturation, the reverse transcriptase responsible for copying the viral genomic RNA into a 
complementary dsDNA molecule and the integrase that modulate the viral integration into the 
cell genome as provirus. The FIV  pol gene encodes an additional protein, dUTPase (DU), 
which  is  a  characteristic  enzyme  of  non-primate  lentiviruses  (Elder  et  al.,  1992)  and 
minimizes the incorporation of uracil  into viral DNA, proving essential for an efficient viral 
replication with stable and correct DNA synthesis (Inoshima, Miyazawa & Mikami, 1998). The 
env gene codes the surface and transmembrane glycoprotein,  which are responsible for 
defining the virus subgroup in FeLV, and subtypes in FIV (Hartmann, 2006; Hosie et al., 
2009). The genetic variation for FIV is greater than that seen for FeLV (Dunham & Graham, 
2008), and the clinical relevance of this variability is that different FIV  env sequences may 
confer different cell tropism and have different pathogenic consequences (Verschoor et al., 
1995; Pancino, Castelot & Sonigo, 1995). Based on these sequence variability within the env 
gene five subtypes, or clades, have been recognized – A, B, C, D and E (Sodora et al., 1994; 
Pecoraro et al., 1996; Nishimura et al., 1998). A sixth subtype – F, has been proposed, but 
not yet fully characterised (Duarte & Tavares, 2006) Among the auxiliary genes of FIV, three 
have been identified and partially characterized. The vif gene is essential for productive FIV 
infection  in  vitro (Lockridge,  Himathongkham,  Sawai,  Chienand  &  Sparger,  1999)  and 
required  for  efficient  viral  replication  in  vivo  during  the  early  stage  of  infection  in  cats 
6 cited by Hartmann, 1998
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(Inoshima et al., 1996). ORF-A is involved in multiple steps of the FIV cycle including both 
virion formation and infectivity (Gemeniano, Sawai, Leutenegger & Sparger, 2003) and the 
rev gene encodes a protein which controls  the cytoplasmic expression of  other FIV viral 
proteins essential for productive infection (Phillips et al., 1992; Tomonaga et al., 1993).
FeLV occurs in nature in four subgroups, designated A, B, C and T, classified first on the 
basis of superinfection interference testing, and later distinguished genetically. Superinfection 
interference is the ability retroviruses have to downmodulate the presence of a particular 
membrane receptor on the infected host cell, thus preventing successive rounds of infection 
of  the  same  cell.  (Mendoza,  Anderson  &  Overbaugh,  2006).  This  interference  reflects 
differences in the genetic sequence of the env gene, more specifically, in the surface protein, 
which  binds  to  different  host  cell  receptors  for  entry.  Only  FeLV-A is  contagious  and 
represents the predominant agent horizontally transmitted from cat to cat (Hartmann, 2006; 
Levy, 2008). Amino acid sequence in the surface proteins of known isolates of FeLV-A has 
been reported to be ~97% identical, in spite of isolation over more than a decade from widely 
different geographic locations (Donahue et al., 1988; Levy, 2008). Subtype B originates from 
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Figure 5 - FeLV (a) and FIV (b) structure and genome.
Major genes: gag – group specific antigen; pol – polymerase; env – envelope. Major viral proteins: MA 
– matrix; CA – capsid; NC – nucleocapsid; RT – reverse-transcriptase; PR – protease; IN – integrase; 
SU  –  surface  protein;  TM  –  transmembrane  protein.  Virion  structure  adapted  from 
http://www.expasy.ch/viralzone/. Genome structure adapted from Dunham and Graham, 2008.
recombination of FeLV-A with the endogenous retrovirus enFeLV and subtype C is the result 
of mutations within the  env gene (Lutz et al., 2009). Subtype T is a highly cytopathic form 
which  evolves  from  FeLV-A as  a  result  of  multiple  mutations  on  the  env gene  and  is 
characterised by its tropism for T lymphocytes (Hartmann, 2006).
None of these retroviruses survive more than a few minutes outside the host and both are 
readily  destroyed by disinfectants,  soap,  heating and drying.  Transmission via  fomites is 
unlikely, but  there is potential for iatrogenic transmission to occur via contaminated needles, 
surgical instruments or blood transfusions (Hosie et al., 2009; Lutz et al., 2009).
FeLV and FIV infections are life-threatening infections which occur globally. Risk factors for 
infection include male gender, adulthood, and outdoor access, whereas indoor lifestyle and 
sterilization are associated with reduced infection rates (Levy, Scott, Lachtara & Crawford, 
2006).  FeLV  prevalence  may  be  influenced  by  the  density  of  cats  and  there  may  be 
noticeable  geographical  and  local  variation.  In  some  European  countries,  the  USA and 
Canada, the prevalence of FeLV infection in individually kept cats seems to be very low, 
usually  less  than  1  %,  but  prevalence  may  be  greater  than  20  %  in  large  multi-cat 
households without specific preventive measures for introduction of FeLV. Over the last 25 
years, the prevalence and importance of FeLV infection in Europe has greatly diminished due 
to  the  availability  of  reliable  tests,  the  test  and  removal  programmes initiated,  improved 
understanding of the pathogenesis and the introduction of highly efficacious FeLV vaccines 
(Lutz et al., 2009). In contrast, the prevalence of FIV has not changed since the virus was 
discovered, in 1986, and is highly variable between regions, with estimates of 1 to 14% in 
cats with no clinical signs and up to 44% in sick cats (Hartmann 1998). 
Cats with FeLV viraemia act as a source of infection. Virus is shed from an infected cat in 
saliva,  nasal  secretions,  faeces  or  milk  and  infection  is  transmitted  mainly  by  mutual 
grooming, but also through bites. In viraemic queens, pregnancy usually results in embryonic 
death, stillbirth or in viraemic kittens which fade away rapidly. In latently infected queens, 
transmission does not  usually  take place during  pregnancy.  Young kittens  are especially 
susceptible to FeLV infection while with age, cats become increasingly resistant to infection, 
although they can still be infected provided the challenge is sufficiently severe (Lutz et al., 
2009). 
The  majority  of  natural  FIV  infections  are  acquired  by  biting,  presumably  through  the 
inoculation  of  virus,  or  virus-infected  cells,  from  the  saliva  of  persistently  infected  cats. 
Transmission from mother to kittens may occur but only a proportion of the offspring become 
persistently infected, depending on the viral load of the queen during pregnancy and birth. 
Cats can be infected by experimental inoculation of virus into the nose, mouth, vagina and 
rectum and virus can be recovered from semen following natural or experimental infection, 
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although none of these has been documented in nature. Queens may still  be infected at 
mating however, if bitten by an infected tomcat (Hosie et al., 2009).
Even  though  FeLV  infection  has  been  considered  more  of  a  concern  for  cats  that  are 
‘friendly’ with other cats, because of the close, intimate contact which facilitates transmission, 
and FIV infection has been viewed as a concern for cats that are ‘unfriendly’ with other cats, 
because of  the  mode of  transmission through bite  wounds,  both  viruses  can be spread 
among cats  that  are  not  known  to  fight  as  well  as  those  that  are  prone  to  aggressive 
behaviour. Characteristics such as gender, age, lifestyle, and health status can be used to 
assess  the  likely  risk  of  FeLV  and  FIV  infections,  but  most  cats  have  some degree  of 
infection risk and less than one quarter of all cats have ever been tested (Levy et al., 2008b).
Although infected cats may experience a prolonged period of clinical latency, a variety of 
disease conditions are associated with retroviral infections, including anaemia, lymphoma, 
chronic inflammatory conditions, and susceptibility to secondary and opportunistic infections. 
FeLV usually infects individual lymphocytes in the oropharynx that are transported to the 
bone marrow, where large amounts of virions are then produced. Viraemia develops within a 
few weeks of infection, leading to the infection of salivary glands and intestinal linings, but 
may  often  develop  only  several  months  after  constant  exposure  to  shedding  cats.  A 
functioning immune system may frequently overcome the development the development of 
viraemia, which is then transient, and so-called “regressor” cats are generally not at risk of 
developing disease. In a multi-cat household without control of FeLV infection, 30-40 % of 
the  cats  develop  persistent  viraemia,  30-40  %  exhibit  transient  viraemia  and  20-30  % 
seroconvert without ever being detectably viraemic. In spite of overcoming viraemia, these 
cats remain latently  infected and reactivation may take place in  vivo in  case of  immune 
suppression  or  chronic  severe  stress,  though  this  is  generally  believed  to  be  a  rare 
occurrence. It appears likely that no cat can completely clear FeLV infection from all cells. 
Although recovered cats appear to have the same life expectancy as cats that have never 
been exposed to FeLV, proviral DNA has been found in the tumours of FeLV-free cats. The 
typical clinical signs of FeLV infection usually develop in viraemic cats, sometimes not until 
after several years of viraemia (Lutz et al., 2009).
Acute FIV infection is associated with transient fever, lymphadenopathy, and leucopoenia but 
frequently  goes unnoticed by cat  owners.  Virus is detected in  high concentrations in  the 
blood by culture and PCR within 2 weeks of infection and both CD4+ (helper) and CD8+ 
(cytotoxic-suppressor) T-lymphocytes decline within the first few weeks of infection (Levy et 
al., 2008b). Latent infection arises when a cell carries an integrated copy of provirus but does 
not produce new virus particles and these cells represent a “reservoir” of infection that is not 
susceptible  to  neutralising  antibodies,  posing  an  obstacle  for  effective  vaccination.  The 
decrease in viral replication controlled by the immune response marks the beginning of the 
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so-called ‘asymptomatic’ phase that can last for many years, or may be lifelong and during 
which the infected cat remains relatively free of clinical signs (Hosie et al., 2009). During this 
time, progressive dysfunction of the immune system occurs, and it is generally recognized 
that  cell-mediated immunity  is  more profoundly  affected  than humoral  immunity.  Chronic 
inflammatory conditions, neoplasia, and infections with intracellular organisms, therefore, are 
more  common than  infections  controlled  by  antibodies  in  FIV-infected  cats  (Levy  et  al., 
2008b). 
Identification and segregation of infected cats is considered to be the single most effective 
method for preventing new infections with FeLV and FIV and the retroviral status of all cats 
should be known because of the serious health consequences of infection influencing patient 
management  both  in  illness  and  wellness  care  (Levy  et  al.,  2008b).  In  general  terms, 
diagnosis of FeLV infection involves the detection of antigen, usually the capsid protein p27, 
which is produced abundantly in most infected cats, while the diagnosis of FIV is aimed at 
detecting antibodies to the capsid protein p24, because of its persistent, life-long infection 
with low viral loads (Hartmann, 2006; Levy et al., 2008b). The most commonly used tests are 
commercially  available  ELISA  assays  or  immunochromatography  tests,  but  the  recent 
introduction of a commercial FIV vaccine, as well as the advances in molecular techniques 
mean that increasing efforts are being made to develop  more sensitive PCR and RT-PCR 
assays, which can provide significantly more information (Hofmann-Lehmann et al.,  2008; 
Hosie et al., 2009; Lutz et al., 2009). 
The first FeLV vaccine was introduced in the USA in 1984 and protected cats from viraemia. 
Since then many breakthroughs have been achieved in recombinant DNA technology, which 
most vaccines on the market  today make use of,  but  different  studies still  report  varying 
levels of efficacy of protection for many of these (Lutz et al.,  2009). Recent studies have 
demonstrated  without  exception  that  cats  that  are  able  to  overcome  p27  antigenaemia 
become provirus positive in the blood and also positive for viral RNA in plasma, although at 
very low levels. These experiments confirm that FeLV vaccination neither induces sterilising 
immunity nor protects from infection and no FeLV vaccine is likely to provide 100 % efficacy 
of protection or prevent infection (Hofmann-Lehmann et al., 2007).
There is a FIV vaccine made from whole inactivated virus preparations available in the USA, 
Australia and New Zealand for some time, but its efficacy has not been tested against a 
range of European field isolates (Hosie et al., 2009). In one study vaccination was shown not 
to protect cats against a virulent UK primary isolate of FIV (Dunham et al., 2006). Neither the 
European Advisory Board for Cat Diseases (ABCD), nor the World Small Animal Veterinary 
Association  (WSAVA)  recommend  vaccinating  cats  against  FIV  given  the  problems 
associated with serological diagnosis of infections and lack of evidence of efficacy against 
European isolates (Day et al., 2007; Hosie et al., 2009).
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2. Materials and methods
2.1 Study population
For the purpose of this study, a sample of 50 dogs and 50 cats from the Lisbon municipal 
kennel was chosen. The animals were euthanized during the period of the study and the 
sample limit of 100 animals was reached after 4 weeks, between October and November 
2008. No living animals took part in this study because of lack of authorization. Information 
regarding  sex,  race,  origin  (captured/relinquished),  clinical  history  and  examination  was 
collected from kennel records where available, after the sampling procedure.
2.2 Sample collection
Euthanasia was performed according to the following protocols: Dogs weighing up to 15kg 
were  administered  10ml  of  sodium  pentobarbital  (Eutasil,  Sanofi  Veterinária,  Portugal) 
intravenously,  followed  by  10ml  of  ether  intravenously.  Dogs  weighing  over  15kg  were 
administered  15-20ml  of  sodium  pentobarbital  (Eutasil,  Sanofi  Veterinária,  Portugal) 
intravenously,  followed  by  15-20ml  of  ether  intravenously.  Cats  were  anaesthetized  with 
intramuscular ketamine followed by intracardiac administration of 10ml sodium pentobarbital 
(Eutasil, Sanofi Veterinária, Portugal).
Around 2ml blood was collected from the cephalic vein of dogs using butterfly needles into a 
5ml syringe prior to pentobarbital administration and then placed in blood tubes with EDTA. 
From cats, blood was collected by cardiac puncture into a 5ml syringe prior to pentobarbital 
administration and then placed in blood tubes with EDTA. Faecal swabs were collected from 
dogs and cats after euthanasia. Samples were taken immediately back to the laboratory and 
kept refrigerated until processed. 
In March 2009, taking into account preliminary results of the survey, environmental swabs 
were collected from cages and cells at the municipal kennel. These cages were randomly 
selected from the same rooms which sampled animals occupied prior to euthanasia. In total, 
24 environmental swabs were collected from 6 occupied cells and cages. The chosen cells 
were sampled every 4 days until we had 4 samples from each.
2.3 Sample processing
Blood samples were centrifuged for 5 minutes at 5000 rpm to separate plasma from blood 
cells and were frozen at -20 ºC. Faecal samples were suspended in phosphate buffered 
saline (PBS) solution and centrifuged for 10 minutes at 10000 rpm. Environmental samples 
were also suspended in PBS and centrifuged for 10 minutes at 10000 rpm.
2.4 Antibody detection
An ELISA kit was chosen for the detection of antibodies to FIV because of its high sensitivity. 
Plasma from all 50 cat samples was analysed using a commercially available kit (Viracheck®/
FIV, Synbiotics), following manufacturer's directions.
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Dog samples were also tested for antibodies to CDV and CPV using ELISA test kits. Without 
any vaccination history, the information gathered from IgG antibody detection alone would be 
of little use. For this purpose, an ELISA test kit which detects IgM specific to CDV (Ingezim 
Moquillo IgM/ Ingenasa) was used to test samples for the presence of antibody titres which 
would indicate recent CDV infection. A CPV test kit for IgM was unfortunately not available at 
the time, so samples were tested for the presence of IgG using a different kit (Ingezim Parvo 
Canino/ Ingenasa).
2.5 Antigen detection
The  detection  of  FeLV  was  performed  using  a  commercial  ELISA kit  (Viracheck®/FeLV, 
Synbiotics) which detects the presence of core viral antigen p27. This antigen is produced 
abundantly in most infected cats (Levy et al., 2008b) and is detected here in its soluble form. 
Because of this, it is a marker of infection, but not always of viraemia (Lutz et al., 2009). 
Though it is possible that about 10% of the cats which test negative to the presence of p27 
antigen are positive by PCR (Hofmann-Lehmann et al., 2001), the specificity of the test is 
close to 100% .
2.6 Nucleic Acid Extraction
Both viral DNA and RNA were extracted from samples of faecal and environmental swabs 
using QIAmp MiniElute Virus Spin Kit  (Qiagen),  following the manufacturer's procedures. 
Nucleic acid was kept at -80ºC until analysed.
2.7 PCR and RT-PCR
Faecal and environmental swabs were tested according to various protocols, depending on 
the virus to detect and were all performed in 25μl reactions. DNA samples were amplified 
using PCR Fidelity Taq 2x Master Mix (USB) and RNA samples were amplified with one step 
RT-PCR  Fidelity  Taq  2x  Master  Mix  (USB).  Primers  used  for  the  different  assays  are 
summarized in Table 4 and thermal cycles in Table 5. 
The detection of Parvovirus was performed on both dog and cat samples using primer pair 
555for/555rev  (Buonavoglia  et  al.,  2001)  which  amplifies  a  583bp  fragment  of  the  gene 
encoding  the  capsid  protein  (Desario  et  al.,  2005).  Primers  and  magnesium  (MgCl2) 
concentration was 50pmol/μl and 2mM, respectively and 5μl of DNA template were used. 
The primers used for detection of CDV in dog samples were described by Frisk et al. (1999). 
The sequence amplifies a 287bp sequence of the nucleoprotein (NP) gene and is localized in 
a highly conserved region of the Ond-CDV strain, sharing high homology among different 
morbiliviruses (Frisk et al., 1999). Primers and MgCl2  concentration were the same as used 
for CPV PCR and 10μl RNA template was added. 
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Table 4 - Primers, position and fragment sizes used for PCR amplification of different viruses












ACA GGA TTG CTG AGG ACC TAT

































































1 – Desario et al., 2005
2 – Frisk et al., 1999
3 – Pratelli et al, 2004b
4 – Herrewegh et al., 1995. Primer numerical position as  determined from the termination codon of 
ORF 7b
5 – Addie et al., 2003
Two pairs of CCoV primers were used, in separate reactions, to amplify a fragment of the 
gene encoding the membrane protein M (Pratelli et al., 2004b). These have the advantage of 
amplifying  two  fragments  of  different  size  depending  whether  CCoV type  I  or  type  II  is 
present  in  the  sample,  respectively,  one  with  239bp  and  another  with  202bp.  Primer 
concentration was 50pmol/μl, MgCl2 was 1.75mM and 5μl RNA template was used.
For detection of FCoV all cat samples were amplified by RT-PCR followed by nested PCR 
(nPCR) (Herrewegh et al., 1995). The primers for this assay amplify a fragment within ORF-
7b,  located at  the  3'  end  of  the  genome and  encode a  highly  conserved  non-structural 
glycoprotein of unknown function (Lin et al., 2009). The first PCR amplifies a 223bp fragment 
and the nested a 177bp one. Primer concentration was the same as above mentioned and 
MgCl2 concentration was 1.5mM and 2mM in the RT-PCR and the nPCR. Ten micro-liters of 
template were used for the first RT-PCR and 1 μl for the nPCR. 
Positive samples to FCoV RNA were subjected to a second RT-PCR and nPCR assay (Addie 
et al., 2003) for differentiation between FCoV type I and II. A universal reverse primer, lubs, 
directed at a conserved region of the spike gene S, and to forward primers, lffs and lcfs, 
directed at specific sequences of the S gene yielded fragments of different size depending on 
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the type of FCoV present, I or II. The nPCR is intended to increase both the sensitivity and 
specificity of the reaction using nested primers nlubs, nlffles and nlcfs, for the same regions. 
Fragment sizes for FCoV type I and II were 376bp and 283 bp for the initial RT-PCR, and 360 
bp and 218 bp for the nPCR. Primers concentration was 10pmol/μl for both forward primers 
and 15pmol/μl for the reverse primer and MgCl2 concentration was raised from 1.5mM to 
2.25mM in the nPCR. The amount of template used was 5 μl in the RT-PCR and 1 μl in the 
nPCR.
All PCR products were detected by electrophoresis in a 1,5% agarose gel and visualized 
using UV illumination after ethidium bromide staining. Comparison of CCoV type I  and II 
positives were analysed on 2,5% agarose gel.









CPV/FPV 94º C / 10 min 94º C/ 30 sec 50º C/ 1 min 68º C / 1 min 68º C / 10 min
40 cycles
CDV 42º C / 45 min 94º C / 2 min 91º C / 45 sec 52º C / 45 sec 68º C / 1 min 68º C / 10 min
40 cycles
CCoV 42º C / 30 min 94º C / 2 min 94º C/ 30 sec 50º C / 45 sec 68º C / 30 sec 68º C / 10 min
35 cycles
FCoV 42º C / 45 min 94º C / 5 min 94º C/ 30 sec 47º C/ 1 min 68º C / 1 min 68º C / 5 min
35 cycles
nPCR
94º C / 1 min 47º C/ 1 min 68º C / 1 min 68º C / 5 min
5 cycles




42º C / 45 min 94º C / 2 min 94º C/ 20 sec 47º C / 45 sec 68º C / 45 sec 68º C / 10 min
35 cycles
nPCR





A total  of  100 samples  from 50 dogs and 50 cats  were  collected.  Kennel  records were 
available only for the dogs in the study, because cats are housed in groups and could not be 
identified  from their  records.  In  some cases,  records  were  incomplete.  Out  of  the  dogs 
tested,  19  (38%)  were  female  and  28  (56%)  were  male.  Twenty-six  (52%)  were  of 
indeterminate race,  13 (26%) were pitbull  and 11 (22%) were of  other identifiable races. 
Eighteen (36%) animals were relinquished by their owners and 32 (64%) were captured by 
municipal services or police forces. Records from clinical examination showed that 28 (56%) 
were “apparently normal”. The most common previous conditions described in examination 
records  were  dermatitis  and  diverse  injuries  (fractures  and  haemorrhages),  followed  by 
conjunctivitis  and  claudication.  Dogs  spent  on  average  24  days  at  the  kennel  before 
euthanasia. These numbers are summarized in table 6.
Table  6 -  Details  from kennel records and distribution of  race,  origin and clinical  examination per 
gender.
Race Origin Clinical examination
Indeterminate 
race






Male 14 7 7 17 11 17 11 28
Female 9 6 4 13 6 9 10 19
Unknown 3 0 0 2 1 2 1 3
Total 26 13 11 32 18 28 22 50
3.2 Laboratory results
3.2.1 Serological results
The ELISA kits for CDV and CPV were used according to the manufacturer's instructions, yet 
the measured optical densities of the negative controls did not validate the tests, therefore no 
conclusions could be drawn about the serological status of these animals.
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Figure 6 - ELISA assay for FeLV with positive (+) and negative (-) controls marked.
All of the blood serum samples tested by ELISA for the presence of FeLV p27 core antigen 
were run in a single plate. The test yielded 5 positive samples (5/50= 10%). The ELISA for 
FIV antibodies resulted in 9 positive samples and 12 inconclusive results were confirmed by 
a second run (9/50= 18%)  (Figure 6).
3.2.2 Nucleic acid amplification results
To assess the sensibility of viral nucleic acid detection several dilutions of Hexadog vaccine 
(Merial), were used for parvovirus PCR and CDV RT-PCR. Both viruses are present in the 
vaccine in a concentration of 103 tissue culture infectious dose 50 (TCID50), and 1/10 serial 
dilutions were performed until 10-4. We detected amplification until the 10-4 dilution in the case 
of CPV and until 10-3 for the CDV (Figure 7). No positive control was available for any of the 
coronaviruses.
3.2.2.1 Dog samples
Faecal samples collected from dogs at the time of euthanasia were processed and tested for 
the presence of CPV DNA, CCoV and CDV RNA. None of the dogs evaluated had clinical 
signs of haemorrhagic diarrhoea, though a few samples had visible traces of blood at the 
time of collection. Out of the 49 dog samples tested, 25 (51%) were positive for CPV nucleic 
acid. Samples were evaluated for the presence of both genotypes of CCoV, and in total there 
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Figure 7 - PCR and RT-PCR results of Hexadog vaccine dilutions used to test sensibility of parvovirus 
and CDV detection.
Lanes 1-5, detection of parvovirus DNA in 1/10 serial dilutions until 10-4; lanes 7-11, detection of CDV 
RNA in 1/10 serial dilutions until 10-4  with amplification only in lanes 9 (10-2   dilutions) and 10 (10-3 
dilutions); lanes 6 and 12, negative controls; M, molecular size marker (100 bp ladder).
were 16 (33%) positives. The assay for the presence of CDV RNA yielded 4 (8.2%) positive 
samples (Figure 8). 
3.2.2.2 Cat Samples
Faecal  samples  were  collected  from  cats  immediately  following  euthanasia  and  these 
samples were tested for the presence of FPV DNA and FCoV RNA. The PCR assay for FPV 
revealed the presence of viral nucleic acid in 34 samples (68%) and the RT-nPCR assay for 
FCoV RNA resulted in 35 (70%) positive samples. Results were observed on agarose gel 
visualized with UV illumination as seen in Figure 9.
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Figure 8 - PCR results for CPV (a), CCoV type I (b) and CDV (c) in dog samples.
CPV (a): lanes 1-12, samples; lanes 13-14, negative controls. CCoV type I (b): lanes 1-10, samples; 
lane 11, negative control. CDV (c): lanes 1-11, samples; lane 12, negative control. M, molecular size 
marker (100 bp ladder).
3.2.2.3 Environmental samples
The high percentage of positive samples for parvovirus DNA and coronaviruses RNA led us 
to evaluate the environmental presence of these viruses. Sixteen samples were collected 
from 4 cells occupied by dogs and 8 samples from 2 cat cages. Eight samples originating 
from 3 different  cells  were  positive for  the presence of  CDV RNA.  Parvovirus DNA was 
present in 15 samples out of 24, including samples from the same 3 dog cells and all of the 
cat cages. None of the environmental samples tested positive for the presence of CCoV, but 
7 samples out of 8 from both cat cages showed amplification of FCoV RNA (Figure 10). A 
summary of the laboratory results is presented in table 7.
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Figure 9 - PCR results for FPV (a) and FCoV (b) in cat samples.
FPV (a): lanes 1-12, samples; lanes 13-14, negative controls. FCoV (b): lanes 1-5, samples; lane 6, 
negative control. M, molecular size marker (100 bp ladder).
Figure 10 - PCR results for CPV and FCoV in environmental samples.
CPV (a): lanes 1-8, samples; lane 9, negative control. FCoV (b): lanes 1-8, samples; lane 9, negative 
control. M, molecular size marker (100 bp ladder).
Table 7 - Distribution of positive results per tested samples
dog cat environment
CDV 4/49 (8.2%) 8/16 (50%)
CCoV 16/49 (32.7%) 0/16 (0%)
Parvovirus 25/49 (51%) 34/50 (68%) 15/24 (62.5%)
FCoV 35/50 (70%) 7/8 (87.5%)
FIV 9/50 (18%)
FELV 5/50 (10%)
3.2.3 Genetic characterisation of coronaviruses
One of the objectives of the virological survey at the municipal kennel was also the genetic 
characterisation of  the viruses  found.  While  there are  plans  to continue this  beyond the 
scope of this dissertation, the only viruses which we had the possibility to genotype during 
this time were the canine and feline coronaviruses. The CCoV were readily characterized 
using the  method and primers  described by  Pratelli  et  al.  (2004b).  Withinin  the 49 total 
samples  16 (32.6%)  were  positive  for  CCoV RNA,  from which  7  (43.8%) samples  were 
genotyped for type I, and 9 (56.2%) for type II. None of the samples tested positive for both 
genotypes. All of these positive samples were re-amplified and visualized on a 2.5% agarose 
gel for better resolution between CCoV type I and type II (Figure 11-a).
Regarding FCoV, 35 positive samples for FCoV RNA (70%) out of the 50 collected from cats 
were  subjected to a  second RT-PCR for  discrimination  between genotype I  and II.  This 
resulted in 9/35 (25,7%) samples which amplified FCoV type I, 6/35 (17%) where FCoV type 
II was detected and 12/35 (34.3%) samples which showed co-infection with both types. No 
amplification was obtained from 8 (23%) samples (Figure 11-b).
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Figure 11 - PCR results of genetic characterisation of CCoV (a) and FCoV (b).
CCoV (a): lanes 1-2, negative controls; lanes 3-11, CCoV type II; lanes 12-18 CCoV type I. FCoV (b): 
odd lanes,  RT-PCR sample prior to nested PCR, with no amplification;  even lanes,  nPCR results 
showing infection with type I (lanes 2, 4 and 8), type II (lane 10) and both types (lane 6). M, molecular 
size marker (100 bp ladder).
4. Discussion and conclusions
A quick search for articles containing the term “virological survey” on PubMed results in more 
than ten thousand hits, with almost one tenth of them written in the last year. A more detailed 
search shows there is a lot  of  diversity among the published works which attests to the 
variety of information which is possible to gather from these studies. 
However, the number of these surveys which aim to ascertain the presence of a particular 
disease  in  a  population  is  actually  diminishing,  in  favour  of  molecular  surveys,  which 
genetically  characterize  and  classify  the  viruses  found.  This  happens  because  the 
technology for phylogenetic analysis is cheaper and easier to perform with each and every 
day,  and because  we  are  more  and  more certain  that  there  is  no  way of  escaping the 
presence of these viruses in any population. Studies regarding viral evolution and phylogeny 
can help determine how we can best deal with these pathogens, especially true in the case 
of high risk populations, such as animal shelters, kennels and wildlife conservation.
In our study we determined by RT-PCR a prevalence of 8% for CDV, which means that 4 
animals out of 49 tested had not only come in contact, but were actually shedding the virus in 
the faeces at the time of sampling. The published literature typically reports the prevalence of 
antibodies to CDV, which means the animals have come in contact with the disease, but may 
or may not be shedding virus. Since the 1950's there have been live attenuated vaccines for 
CDV which have effectively reduced the incidence of the disease, especially in Europe and 
North  America,  and  so  most  of  the  virological  surveys  have  focused  on  stray  and 
unvaccinated dogs, or wild animals. In Turkey Gencay et al. (2004) evaluated sera collected 
from 609 dogs by virus neutralization assay and reported a seroprevalence of 9.03%. Most of 
the animals were housed in shelters or rehabilitation centres with no clear vaccination history, 
but the highest antibody titres were also below the considered protective level. In Zimbabwe 
unvaccinated dogs in communal lands were tested by ELISA for antibodies to CDV, resulting 
in 82% prevalence, which means that not only are these rural dogs commonly exposed to the 
virus, but also that a substantial number survive (Kelly, Musuka, Eoghin, Tebje-Kelly & Carter, 
2005).  The  prevalence  of  antibodies  detected  by  indirect  fluorescent  assay  in  Iran  was 
17.52% in 97 samples taken from unvaccinated dogs in the rural areas surrounding the city 
of Ahvaz between 2004 and 2005 (Avizeh, Shapouri & Akhlaghi, 2007). A higher prevalence 
of CDV detected by RT-PCR (73.8%) was reported by Calderon et al. (2007), by analysing 
99 samples submitted during 2003 and 2004 for diagnostic purposes. In spite of the fact that 
most of the samples were obtained from animals which had been vaccinated at least once, 
89% of the positive animals showed typical symptoms of CDV, confirming clinical disease 
which  might  be  caused  by  the  emergence  of  viral  variants,  or  by  improper  vaccination. 
Dezengrini, Weiblen and Flores (2007) reported an antibody prevalence of 27.3% in 817 sera 
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collected from unvaccinated animals in several neighbourhoods of Santa Maria, Brazil, which 
were  submitted  to  a  virus  neutralization  assay.  On  Isabela  island,  in  the  Galapagos, 
vaccination of dogs and cats, as well as movement between the islands and continent is 
forbidden due to the Galapagos unique biodiversity and conservation status, which believes 
that these and other introduced species are the greatest threat to the local wildlife. Levy et al. 
(2008a) hypothesized that due to this isolation, the population of dogs and cats would be 
protected from diseases common in the mainland, but nonetheless reported a prevalence of 
22% for antibodies to CDV, determined by virus neutralization.
Taking into account previous studies and characteristics of the study population, which has a 
high density and a high turnover, the prevalence of this virus in the animals at the municipal 
kennel is  not  particularly high. One of the reasons for this finding might  be the fact that 
animals in and around Lisbon area are commonly vaccinated. However, another explanation 
could be that the younger dogs which are more at risk of developing the disease weren't part 
of this study because of the sampling method (euthanasia). It is possible that the positive 
animals we found had chronic infections characterized by viral persistence and low shedding 
exacerbated by the stress of capture. It would have been interesting to evaluate antibodies 
titres to  CDV by ELISA,  but  the lack of  information regarding the vaccinal  status of  the 
animals could have lead to a misleadingly high number. In spite of the high lability of CDV 
virions,  we found evidence of  environmental  contamination by viral  RNA in a cell  with  a 
possibly infected animal,  which was euthanized,  but  not  tested.  During the following two 
weeks after this dog's euthanasia, environmental swabs taken from the cell tested positive 
for viral RNA, indicating that sanitization procedures weren't optimal.
Recent reports of vaccination failures and detection of viral variants distinct from the vaccine 
strains  have  resulted  in  an effort  by  researchers  to  characterise  the  CDV from different 
populations. The high genetic diversity of RNA viruses has been implicated as responsible for 
this phenomenon,  but only recent  phylogenetic studies have proved without a doubt  that 
there are genetically different strains of CDV in circulation worldwide. An interesting report by 
Lednicky et al. (2004) identified more virulent strains responsible for a higher mortality rate 
among free-ranging raccoons around a large Chicago zoo, which were distinct from typical 
American CDV lineages. The same distinct strains may also have been responsible for a 
serious CDV outbreak among shelter dogs in the Chicago area in late 2004, affecting also 
vaccinated dogs, according to Kuehn (2004). Pardo, Johnson and Kleiboeker (2005) also 
characterised CDV strains which caused the death of puppies in the USA and concluded that 
none of the strains had ever been previously detected in continental America and might have 
originated from non-canine species with phylogenetic relationship to European seals, minks 
and even Chinese pandas, thus explaining why the vaccinated puppies were not immunised. 
In Italy, several strains from dogs and one fox were analysed philogenetically and clustered 
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in three distinct lineages (Martella et al., 2006). The sequence of the H gene was used to 
identify lineages, named for the geographic location of their isolates, and subsequent studies 
have mostly used the same nomenclature. The majority of samples displayed high genetic 
homogeneity with the European lineage, but unexpectedly, two unrelated samples, including 
one from a vaccinated pup, were more closely related to the Arctic lineage, raising questions 
on  the  epidemiology  of  these  unusual  strains  and  whether  they  represent  occasional 
findings. The fox strain was only distantly related to the European lineage suggesting the 
existence  of  non-urban  epidemiological  cycles  responsible  for  the  maintenance  of  these 
atypical CDV strains in wildlife. Further studies added more details, and more branches to 
the CDV phylogenetic tree. Argentinian isolates formed a separate lineage, which was more 
related to Asian strains (Calderon et al., 2007), while Hungarian isolates were diverse, with 
the most prevalent lineage being the Arctic (Demeter et al., 2007). The authors suggested 
that this heterogeneity may be caused by the lack of geographical barriers and uncontrolled 
movement of domestic and wild animals throughout Europe.  Kapil  et  al.  (2008) analysed 
seven samples from dogs which had died of CDV in the USA and also grouped them in the 
European  wildlife  and  the  Arctic  lineage,  showing  that  movement  of  dogs  infected  with 
different  strains  is  also  intercontinental.  Further  studies  are  needed  in  order  to  better 
understand if  the rise  of  novel  CDV strains  caused by  antigenic  drift  and shift  are  truly 
responsible for the recent reports of vaccination failure.
Canine coronavirus RNA was present in the faeces of 33% of the 49 animals sampled from 
the municipal kennel in our study. As for CDV, most of the studies published investigate the 
presence of antibodies to CCoV. Vaccination against coronavirus is still uncommon in most 
countries and in fact controversial due to adverse postvaccinal reactions and low efficacy of 
engendered immunity (Pratelli 2006). The duration of immunity is still to be determined, but 
antibodies caused by natural exposure seem to decay rapidly (Zarnke et al., 2001). In a UK 
rescue kennel, the virus was isolated by Tennant, Gaskell, Jones and Gaskell (1993) in 45% 
of faecal samples collected, from dogs with and without diarrhoea, but the seroprevalence in 
the same kennel was 76%. In 1999, Bandai et al. performed an extensive virological and 
epidemiological study to characterise the situation in Japan regarding CCoV infections. The 
seroprevalence reported for  467 dogs in  animal  shelters  was 44.1% and viral  RNA was 
detected by RT-nPCR in 16% of 100 stool samples from diarrhoeic dogs. Naylor et al. (2001) 
developed an indirect ELISA for the detection of IgG and IgM with the objective of surveying 
antibodies to CCoV among different dog populations in Australia and evaluating the role of 
this  virus as a causative agent  of  gastroenteritis.  Out  of  1396 serum samples analysed, 
40.8% of the animals housed in kennels had antibodies to CCoV, as opposed to only 15.8% 
of the animals housed in the open. The role of IgM to help determine recent infections was 
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shown  by  the  high  prevalence  of  these  antibodies  in  animals  with  clinical  signs  of 
gastroenteritis  (85%),  in  comparison  to  15%  in  dogs  without  any  clinical  history  of 
gastroenteritis,  which still  had a 30% seroprevalence of IgG. In Turkey, Yeşilbağ, Yilmaz, 
Torun and Pratelli  (2004) tested 179 dogs by serum neutralization assay, yielding 62.5% 
positive samples, and further 90 samples from diarrhoeic puppies were assayed by RT-PCR 
resulting in 15.5% positives. In 2005, Sokolow et al. (2005) performed an epidemiological 
evaluation of  diarrhoea in  dogs in  an animal  shelter  in  California,  USA, collecting faecal 
specimens from 60 case dogs (with diarrhoea) and 60 control dogs. Detection of CCoV was 
done by RT-PCR and 73.3% of  case dogs tested positive,  as opposed to 59.3% of  the 
control dogs, showing that there was no significant difference and CCoV was not associated 
with diarrhoea, but instead was nearly ubiquitous in the kennel population. Priestnall, Pratelli, 
Brownlie & Erles (2007) assessed the serological prevalence of CCoV in southern Italy and 
analysed its epidemiologic relationship with CRCoV. They concluded that the seroprevalence 
of CCoV depends heavily on the sampled dog population with 97% of positive pups from 
shelters with outbreaks of enteric disease, compared to 86.1% of adult dogs and 73.4% from 
a previous study in the same area. The authors also suggested that the high prevalence was 
caused by continuous reinfections from the environment or by the development of chronic 
infections in some animals. In Santa Maria, Brazil the seroprevalence of CCoV was 50.4% in 
the previously mentioned study by Dezengrini et al. (2007). Recently, Stavisky et al. (2009) 
carried out a cross-sectional  study survey of  randomly selected veterinary practices from 
throughout the UK targeting both diarrhoeic and asymptomatic dogs for detection of CCoV 
RNA by RT-PCR in faecal samples. This resulted in a prevalence of 2.8% positive dogs (7 
out of 249), of which 3 dogs lived in the same household and none had presented at the 
veterinary practices with clinical signs of diarrhoea. Confronted with a prevalence which was 
lower  than  expected,  the  authors  suggested  that  the  variability  of  prevalence  estimates 
depend on factors  such as the  detection  methods used,  the characteristics  and disease 
status  of  the  dog population  under  study  and the  possibility  that  CCoV prevalence in  a 
population might fluctuate over time.
The prevalence of CCoV infections at the municipal kennel in Lisbon is in agreement to other 
studies which state that the virus is practically endemic in kennel populations. While the lack 
of widespread vaccination means that positive serological results will almost surely indicate 
exposure to the pathogen, the fact that antibodies to CCoV seem to decay rapidly, questions 
the usefulness of these methods. The high turnover rates of animals in shelters seems to 
assure the establishment of the virus in susceptible populations, either by chronic infections 
with continuous viral shedding, or by repeated reinfection from the environment and other 
dogs. None of the environmental samples collected from the dog cells tested positive for the 
presence of CCoV, but this can be simply caused by the small number of cages sampled. 
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Eight of the positive animals in our study also tested positive for CPV, which is in agreement 
with the involvement of CCoV in mixed infections. Although this finding can be due to an 
important  environmental  presence of  CPV,  none of  these animals  had  clinical  history  of 
diarrhoea, supporting the idea that CCoVs aren't  usually related to clinical disease in adult 
dogs. The role of this agent in the epidemiology of gastroenteritis is still poorly understood, 
but  it  is  clear  that  co-infections with other agents,  such as CPV,  can be responsible for 
mortality and efforts must be made to reduce its prevalence in kennel populations.
There  has  been  renewed  interest  in  the  genotyping  and  molecular  characterisation  of 
CCoVs,  because  of  its  close  relationship  with  the  feline  coronavirus,  which  can  be 
responsible for fatal disease in cats, and also because of the recent discovery of a group 2 
canine coronavirus (CRCoV) which is closely related to the SARS-CCoV affecting humans. 
Recent  studies  identified  different  CCoV  genotypes,  whose  genetic  and  pathogenic 
characteristics are not yet fully understood, but which already seem to be widespread in the 
dog population. Pratelli et al. (2003a) first described the genetic diversity found among CCoV 
isolates from dogs with diarrhoea in Italy by sequencing and analysis of the S gene, showing 
that there were samples which were highly divergent from the reference strains and more 
closely related to FCoV type I. In a subsequent study, Pratelli et al. (2004b) designed an RT-
PCR assay which  allows the differentiation  of  both genotypes.  They confirmed the wide 
diffusion of both genetic lineages as well as the occurrence of simultaneous infection with 
both genotypes and reported prevalences of 14.5% for CCoV type I, 8.7% for CCoV type II 
and 76.8% for both. In Sweden, Escutenaire et al. (2007) performed a phylogenetic analysis 
on both the M and the S gene amplified from samples of diarrhoeic dogs with intriguing 
results. Most samples clustered closer to the CCoV type II identified in Italy based on the M 
gene sequences, but two samples showed contradictory clustering based on the S gene, 
supporting the idea that co-infection with genetically different viruses favours the occurrence 
of recombination events, and that viral populations in the same environment may be complex 
and represented by distinct genetic variants.
The distribution of CCoV genotypes found in our study was very different than previously 
reported, since the prevalence of both genotypes was almost the same (43.8% to 56.% for 
types I and II, respectively) and none of the animals was positive for both genotypes. The 
kennel  environment  could  provide  these  viruses  with  extensive  opportunities  for 
recombination  events  because  of  the  high  turnover  and  density  of  animals,  including 
opportunities  of  infection  by  feline  and  canine  coronaviruses  in  the  same  animal. 
Unfortunately,  these results  would  only  be further  clarified  by  sequencing  and  extensive 
phylogenetic analysis of the collected samples, which was not feasible at the time.
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The evolution of parvoviruses and their diagnostic has changed in the last 30 years, and the 
emergence of new viral variants have caused this disease which was once controlled by 
vaccination in domestic animals, to be the target renewed research efforts. This is one case 
where  most  of  the  current  scientific  literature  focuses  on  molecular  methods  and 
phylogenetic analyses and most of the studies on the disease prevalence are geared toward 
wildlife  and  wildlife  conservation.  In  our  work  we  detected  a  prevalence  of  51% in  dog 
samples and 68% in cat samples from the municipal kennel analysed by PCR. One of the 
earliest studies on seroprevalence of CPV was undertaken in Ontario, Canada, by Carman 
and Povey (1984), during the years after CPV-2 was first isolated. Canine sera from dogs 
presented to the Ontario Veterinary College between 1976 and 1980, were assayed for CPV 
antibodies using a hemagglutination inhibition (HI) test. The first positive sera are from 1978, 
the same year as the first isolation of the virus in the USA, and by 1980 there were 31.2% of 
dogs  with  antibodies  to  this  new  virus.  Dezengrini  et  al.  (2007)  submitted  sera  from 
unvaccinated dogs in Santa Maria, Brazil, to an HI assay which resulted in a prevalence of 
68.7%. According to the authors this number was lower than previously reported in Brazil, but 
the sampling method used tested only animals which hadn't been vaccinated against CPV. In 
the Galapagos, dogs and cats submitted to a neutering campaign on Isabela Island, were 
tested for the presence of antibodies to CPV by HI and to FPV by ELISA by Levy et al. 
(2008a). In spite of the isolation of these animals the prevalence for CPV was 100% and for 
FPV 67%. Blanco et  al.  (2009) assayed the sera of  97 domestic cats in  Costa Rica for 
antibodies  to  FPV,  resulting  in  92.8%  positives,  of  which  17.8%  had  been  previously 
vaccinated with a modified live vaccine.
The prevalence for parvovirus in both cats and dogs at the municipal kennel was particularly 
high, but not unexpected when dealing with a virus which is shed in such high quantities and 
is  highly  resistant  to  environmental  conditions.  As  expected,  there  was  a  strong 
environmental contamination and only one of the six cages from both dogs and cats had no 
positive  results  during  our  sampling.  It  was  interesting  to  note  that  most  infections  with 
parvovirus in dogs were sub-clinical and veterinarians at the kennel registered no signs of 
haemorrhagic diarrhoea for most of the animals. On the contrary, there was a large mortality 
of cats which they attributed to feline panleukopenia, though no confirmatory diagnosis was 
available.  The  contaminated  environment  precludes  any  possible  hypothesis  of  previous 
exposure to the virus and the only way to remedy this situation would have been a different 
sampling methodology, testing animals upon entry in the kennel, for example. Parvovirus is 
one of the most difficult pathogens to eradicate in a shelter environment and only concerted 
efforts combining, testing, vaccination, and sanitization can hope to succeed.
The characteristics  of  parvoviruses  and their  recent  evolution  are  still  a  current  topic  of 
interest among virologists and efforts are still made to understand the antigenic differences 
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and phylogenetic relations between different genotypes. The characterisation of CPV type 2c 
near  the turn of  the millennium spurred a new wave of  publications which  attempted to 
describe  the  epidemiology  of  CPV  and  its  newest  genotype,  as  well  as  its  genetic 
characteristics. Ikeda et al. (2000), reported that 80% of isolates from cats in Vietnam and 
Taiwan were of the CPV type, and sequence analysis described a new antigenic type present 
in the Asian cat population. A genotype with a different mutation was identified in Italy by 
Buonavoglia et al. (2001) and went on to spread throughout the continent in a couple of 
years. The new type 2c variant was detected by 2006 in most of the European countries, with 
high prevalences in Italy, Portugal and Germany (Decaro et al., 2007a; João Vieira et al., 
2008), and had also crossed the Atlantic to North America (Hong et al., 2007; Kapil et al., 
2007) and South America (Calderon et al.; 2009; Pérez et al., 2007). A recent report from 
Clegg, Coyne, Gaskell, Dawson & Radford (2009) found evidence of geographic clustering 
within different cities in the UK when sequencing the full VP2 gene, indicating that the virus 
suffers continuous mutations in sites other than the key amino acid sites used to identify 
different types, which may have important ramifications for disease control. Even if the full 
significance of  these mutations and geographic  clustering is unknown it  is  clear  that  the 
continuous evolution of parvovirus will eventually allow the emergence of new CPV types 
which could possibly break through the antibody barrier, meaning that surveillance is of the 
utmost importance, especially in shelter environments.
Feline coronaviruses are considered ubiquitous pathogens of the cats and the prevalence of 
FCoV  varies  considerably  between  different  populations,  depending  on  several  factors. 
Recent studies have focused, therefore, more on the interactions between virus and host and 
virulence  factors  causing  the  fatal  feline  infectious  peritonitis.  Seroprevalence  has  been 
reported in several studies to be between 80 and 90% in catteries and between 10 and 50% 
in single cat-households (Herrewegh et al., 1995). There were 70% of cats in the municipal 
kennel  in  Lisbon  shedding  the  virus  in  faeces,  as  determined  by  RT-PCR assay.  Kiss, 
Kecskeméti, Tanyi, Klingeborn & Belák (2000) evaluated 113 cats living in urban areas in 
eastern Hungary which presented at private veterinary practices for routine examination with 
the objective of determining the prevalence of asymptomatic FCoV carriers. Samples were 
submitted to an RT-PCR assay targeting a highly conserved region of the N gene, resulting in 
31.8% of positive animals, of which 45.2% were pure-bred and 23.9% mixed breed. Luria et 
al.  (2004)  evaluated  feral  cats  in  Florida  for  the  presence  of  antibodies  to  FCoV using 
immunofluorescence antibody assay and 18.3% of the tested cats had antibodies, most of 
which had low titres. Based on immunofluorescence tests, Kummrow et al. (2005) reported a 
50% prevalence among healthy cats in Switzerland (with no clinical signs associated with 
disease or FCoV infection) with antibodies against FCoV, representing a more than twofold 
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increase in prevalence since the previous study (Lutz et al., 1990), which could be caused by 
differences in sample selection, serologic tests, or reflect a true increase in seroprevalence. 
In Bursa, Turkey, 100 sera belonging to catteries, community shelters and households were 
tested by Pratelli  et  al.  (2008) for the presence of antibodies using a virus neutralization 
assay  and  the  reported  prevalence  was  21%.  Holst,  Englund,  Palacios,  Renström  and 
Berndtsson (2006) analysed 209 serum samples from healthy cats visiting veterinary clinics 
in Sweden, with the objective of determining the prevalence of antibodies to FCoV in cats 
without  signs  of  infectious  disease.  The  overall  seroprevalence,  determined  by  indirect 
immunofluorescent tests, was 31% and was significantly higher among pure-bred cats (65% 
versus  17%)  and  among  cats  living  in  groups  of  at  least  five  (79% versus  29%).  One 
previous study in Portugal by Duarte et al.  (2009 submitted) evaluated samples collected 
from stray and feral cats captured for a neutering program in the metropolitan area of Lisbon. 
Stool samples and rectal swabs from 127 cats were evaluated by RT-nPCR for FCoV RNA 
with 7.1% positives. The authors suggest that the lower prevalences found in this study could 
be explained by the fact that stray cats aren't subject to confinement, which would reduce the 
odds of infection when compared to shelters and multi-cat environments.
Regarding FCoV,  the prevalence found was higher  than reported in  other  countries  and 
significantly higher than previously found in stray cat population in Portugal (Duarte et al., 
2009, submitted). Ever since the discovery of the relationship between feline coronavirus and 
the fatal disease feline infectious peritonitis, there have been increasing efforts to control the 
viral  spread  by  segregation  and  sometimes  vaccination,  but  the  single  most  important 
measure  in  the  fight  against  this  virus  is  strict  hygiene.  Ideally,  cats  should  be  housed 
separately,  but  the  large  number  and  heavy  rotation  of  animals  in  the  municipal  kennel 
makes it difficult to implement an efficient sanitization procedure. Most of these stray cats 
may have never experienced FCoV infection before entering the kennel premises and there 
is a heavy presence of viral nucleic acid in the environment, but since the adoption rate of 
these animals is lower than that of dogs, most of them are euthanized before presenting any 
possible clinical signs of FIP. Still, efforts should be made to improve the hygiene in the cat 
rooms at the kennel in order to lower the prevalence of this infection.
There is  evidence that  both genotypes described for  FCoV are able to  develop FIP,  but 
contradictory numbers have been reported by researchers worldwide on the prevalence of 
the two different genotypes, as well as their association with the development of FIP. In the 
municipal kennel there were 25.7% of cats infected with type I, 17% infected with type II and 
34.3% were  infected  with  both  types.  In  Japan,  Hohdatsu  et  al.  (1992)  determined  by 
competitive  ELISA using  monoclonal  antibodies  against  FCoV that  type  I  was  the  most 
common serotype, with 69% among natural cases of FIP and 100% among asymptomatic 
animals. However, it was still the largest prevalence of FCoV type II reported to date. As part 
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of a larger study of FCoV endemic infection in households throughout the UK, Addie et al. 
(2003) developed an RT-nPCR assay to differentiate the two FCoV genotypes and reported a 
prevalence of 97% of samples positive for type I. Upon further analysis of the samples by 
nucleotide sequencing the authors reported mutations which support the idea that there are 
many geographical differences among FCoV strains and also concluded that superinfection 
with more than one strain at the same time is uncommon, although possible. Benetka et al. 
(2004) retrospectively tested samples from cats which had FIP verified by histopathological 
lesions in Austria. Out of 74 samples, 86% were positive for type I, 7% for type II and 7% 
were positive  for  co-infection  with  both  types,  suggesting  the  involvement  of  both FCoV 
genotypes in FIP and postulating that contact with dogs excreting CCoV is necessary for the 
emergence  of  type  II  in  the  field.  In  Switzerland,  Kummrow et  al.  (2005)  confirmed  by 
immunofluorescent  assay  that  the  prevalent  serotype  for  FCoV was  type  I,  with  35.1% 
prevalence among healthy cats and 83% among animals with a confirmed FIP diagnosis. 
Interestingly, while 4.4% of the healthy cats had higher antibody titres to FCoV type II, 10.5% 
of the cats in this group and 17% of the animals diagnosed with FIP had identical titres for 
both  serotypes.  Unfortunately,  the  serological  tests  used  in  the  study  did  not  allow  the 
differentiation between animals infected by both serotypes at the same time or consecutively, 
or even rule out the the presence of different strains with similar immunological properties. 
Among  diseased  animals,  antibodies  against  type  I  were  overrepresented,  but  not  at  a 
statistically  significant  level.  Another  retrospective  study  in  Taiwan  on  clinical  specimens 
collected between 2003 and 2007 from both asymptomatic as well as clinically confirmed FIP 
cases analysed by RT-nPCR the distribution of FCoV genotypes. Type I was prevalent in 
54.3%,  type II  in  3.6% and both  genotypes were  detected in  3.3% of  the samples,  but 
surprisingly  there  was  a  significant  correlation  between  infection  with  type  II  and 
development  of  FIP  (Lin  et  al.,  2008).  In  Portugal,  Duarte  et  al.  (2009)  evaluated  the 
molecular epidemiology of FCoV for the first time in the country using samples collected for 
laboratory diagnosis at the Veterinary Hospital of the Faculty of Veterinary Medicine. Among 
57 samples positive for viral RNA, 79% were classified as type I and only 3.5% as type II, 
while no amplification was obtained from 17.5%. These samples were further analysed by 
heteroduplex mobility  assay and nucleotide  sequencing,  which revealed that  21% of  the 
samples  were  positive  for  viral  quasispecies,  found within  the  same animal,  but  also  in 
samples collected from multi-cat households. While no conclusions could be drawn regarding 
the association of any particular FCoV genotype with disease, an interesting fact was the 
confirmation  that  nucleotide  sequences  from  the  type  II  samples  showed  a  more 
homogeneous  distribution  of  sequences  than  type  I,  including  a  high  similarity  between 
geographically distant isolates from previous studies.
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The distribution of FCoV genotypes in our study is unique because of the high prevalence of 
type II virus and even higher prevalence of co-infections with both types. The majority of 
FCoV infections reported worldwide are due to type I viruses and it's not known whether type 
II is transmitted naturally among cats (Addie et al. 2003). While there is evidence that the 
appearance of FCoV type II is the result of a double recombination event between FCoV I 
and CCoV II (Herrewegh et al., 1998), some authors are of the opinion that animals have to 
be infected by both parental viruses in order for type II to be detected (Petter J.M. Rottier, 
personal  communication,  24th August,  2009).  It  is  a  known  fact  that  several  group  1 
coronaviruses cross-react in virus neutralization tests, to the point that Horzinek, Lutz and 
Pedersen  (1982)  suggested  that  TGEV,  FCoV  and  CCoV  be  regarded  as  host  range 
mutants. Recently, Le Poder et al. (2009) were able to identify CCoV type I in a naturally 
infected cat living with a dog, infected with the same strain. On the other hand, reports of 
cats with no known contact with dogs infected with type II viruses exist, and the high degree 
of similarity between the sequences of isolates from geographically distinct locations lead us 
to believe that this newer genotype has spread into the cat population and occurs naturally. 
The implications for  our study are important,  because these animals are living in a very 
closed environment where there are plenty of chances of infection by both viruses, in both 
hosts. Further studies should be conducted to analyse the strains present in this population, 
but there is sufficient evidence that superinfection of cats with multiple strains of the virus is 
possible  in  a  heavily  contaminated  environment.  The  nucleotide  sequencing  would  be 
especially useful in cases where the RT-nPCR assay could not amplify either genotypes, 
which could be due to the presence of quasispecies which the  primers do not detect. It is 
probable that the evolution of these viruses will reach a point in the future where it is no 
longer possible to separate them into neatly arranged genotypes, but only in clusters with 
varying degrees of phylogenetic relationship. It  would have also been interesting to know 
more about the role of double infections in the development of FIP, but unfortunately we had 
no clinical data available on these animals to reach any conclusion.
FIV has been demonstrated to be endemic throughout cat populations worldwide by various 
serological  surveys  since its  discovery  in  1986,  and seroprevalences are  highly  variable 
between  regions.  While  a  vaccine  against  this  disease  is  available,  it  is  actually  not 
recommended  by  the  most  recent  vaccination  guidelines  from  the  World  Small  Animal 
Veterinary  Association  (WSAVA),  because  of  its  interference  with  the  most  common 
diagnostic tests (Day et al., 2007). Cat sera in our study were assayed for the presence of 
antibodies to FIV by ELISA which resulted in a seroprevalence of 18%. In Madrid, Arjona et 
al. (2000) evaluated one group of healthy cats and another group of cats which presented 
typical signs of retroviral infection for the presence of antibodies against FIV. Among the cats 
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in the healthy group, 8.3% were positive, while 13.9%. of the sick cats were FIV positive, 
which proved that an important percentage of cats infected with FIV have no clinical signs. 
Almost two thousand free-roaming cats admitted to neutering programs in the USA were 
tested  by  ELISA for  antibodies  against  FIV.  In  spite  of  the  fact  that  these  cats  were 
considered a high-risk population, the overall prevalence of 3.5% is similar to infection rates 
reported for owned cats (Lee, Levy, Gorman, Crawford & Slater, 2002). Owned cats referred 
to veterinary hospitals in Japan were assayed for FIV antibodies using a commercial kit and 
among 1088 animals, 9.8% tested positive. The same study showed a significantly higher 
seroprevalence in males and cats with outdoor access (Maruyama et al., 2003).  In Florida, 
USA, Luria et al. (2004) sampled 553 feral cats  as part of a TNR program and evaluated the 
presence of antibodies to FIV, with a prevalence of 5.2%. They concluded from the similar 
prevalences that the cats assayed in the study did not present a higher risk to domestic cats 
than pet cats. Little (2005) tested a total of 246 cats from several different groups in Ottawa, 
Canada, for antibodies to FIV using an in-hospital ELISA kit, resulting in 11% positives and a 
similar  prevalence  for  both  the  feral  and  client-owned  group.  One  of  the  largest 
seroprevalence studies ever performed on retroviral infections in cats was undertaken by 
Levy et al. (2006), where 18038 samples from 345 veterinary clinics and 145 animal shelters 
were  tested  using  a  commercial  ELISA  kit  and  risk  factors  were  analysed.  The 
seroprevalence  for  FIV  was  2.5% and  the  risk  factors  identified  are  in  agreement  with 
previous  studies  which  indicate  male  cats,  with  outdoor  access  as  the  highest  risk 
population. However, cats in all categories were considered at risk and current guidelines to 
test  all  cats with  unknown status and again in  the event  of  sickness should be followed 
whenever  possible.  Very  different  prevalences  were  reported  by  Norris  et  al.  (2007)  in 
Australia, where feral cats from two colonies showed a seroprevalence of 21 and 25%, while 
the  prevalence  in  cattery-confined  pedigree  cats  was  nil  and  the  prevalence  in  the  pet 
population sampled from veterinary clinics was 8%. The authors cite population density as 
one  explanation  for  the  higher  prevalence  found in  the  feral  cats  in  this  study,  and  the 
efficacy of FIV screening and an indoor lifestyle as preventive measures against the spread 
of this disease. During the year of 2004, Murray, Roberts, Skillings, Morrow and Gruffydd-
Jones (2008) collected test results regarding FIV prevalence from 7098 cats which entered 
adoption  centres  in  the  UK,  with  an  overall  value  of  3.1%  positives.  In  the  previously 
mentioned study by Blanco et al. (2009) in Costa Rica, the seroprevalence for FIV was 8.8% 
with  a  higher  prevalence  in  male  cats.  Gleich,  Krieger  and  Hartmann  (2009)  recently 
published  the  results  of  10  years  worth  of  FIV  testing  in  Germany,  which  they  used  to 
conclude that the FIV prevalence of 3.2% did not change significantly during the study years 
and  identified  once  again  the  most  important  risk  factors  as  male  cats  with  aggressive 
behaviour and outdoor living style. Furthermore, they determined from interviews with the 
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owners  of  infected  cats  that  the  median  survival  time  for  FIV  positive  animals  was  not 
significantly  different  compared to  non-infected cats.  In  the  recent  survey  in  Portugal  by 
Duarte et al. (2009, submitted), the prevalence of stray cats from the Lisbon urban area with 
FIV antibodies was 13.8%.
The prevalence of FIV in cat populations seems to depend greatly on the characteristics of 
the study population, as well as their past exposure to the agent. Lifestyle, gender and health 
status of the animals affect the infection rate and there seems to be a noticeable difference in 
prevalences between Northern Europe and Southern Europe, where higher prevalences are 
reported.  The  infection  rate  in  our  study  was  higher  than  previously  reported  in  Madrid 
among healthy  owned  cats  (Arjona  et  al.,  2000),  but  similar  to  the  prevalence  reported 
recently in stray cats in Lisbon (Duarte et al.,  2009 submitted), the same area where the 
animals in the kennel were captured from. Since the virus survives only minutes outside the 
host and is susceptible to all disinfectants we didn't test for its presence in the environment 
and judging from the average time these animals spend at the kennel,  it's reasonable to 
conclude that the positive samples came from cats infected prior to capture. Portuguese FIV 
isolates  display  a  unique  viral  genetic  diversity  where  most  samples  group  within  a 
subcluster of the subtype B and a few sequences seem to cluster within a newly proposed 
subtype F (Duarte & Tavares, 2006). The sequence analysis of the samples from stray and 
feral  cats  at  the municipal  kennel  could provide a better  understanding of  the molecular 
epidemiology of FIV in the country and perhaps support the assignment of a new subtype.
The improved understanding of FeLV pathogenesis, specially of “carrier” states, along with 
he introduction of reliable vaccines and diagnostic procedures aimed at identifying infected 
animals and preventing disease spread, have contributed to the decrease in the prevalence 
of this disease over the last 25 years. Recent advances in molecular techniques have added 
a whole new dimension to the diagnostic  of  this  disease and its  latent  infections,  but  in 
practical  terms the  most  popular  techniques are  the  ELISA and  immunochromatography 
assays for detection of p27 antigen. Due to the importance of this disease in both in domestic 
as well as in wild felines, and its close relation to FIV, they are usually tested together and 
most of the surveys referred next have been mentioned previously. The proportion of cats 
from the municipal kennel in Lisbon which tested positive to the presence of FeLV antigen by 
ELISA was 10%. Previous studies have reported prevalences of 15.6% in healthy cats and 
30.4% in sick cats in Madrid (Arjona et al., 2000), while in the USA this value was 4.3% (Lee 
et al., 2002). In Japan, this prevalence was 2.9% in owned cats (Maruyama et al., 2003), 
3.3% in feral cats in Florida (Luria et al., 2004) and 2.3% in a large sample including owned 
and shelter cats from all over the USA (Levy et al., 2006). Blanco et al. (2009) reported a 
prevalence of 16.7% among owned cats in Costa Rica at a time when the vaccine still wasn't 
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available in  the country,  while  Gleich et  al.  (2009) reported a significant  decrease in  the 
prevalence of FeLV in Germany over a 10 year study, from 6% to 1% between 1993 and 
2002, with an overall prevalence of 3.6%. The latest survey in Portugal among stray and feral 
cats reported a prevalence of 7.7% positive cats, with a larger proportion of infected animals 
younger than one year (Duarte et al., 2009, submitted).
The number of infected cats at the municipal kennel reflects the fact that these are stray 
animals, which aren't tested, vaccinated or segregated to keep prevalences down, but they 
are also similar to previous reports from the Iberian Peninsula. Just like FIV, the virus doesn't 
survive long outside the host and it's easily inactivated, which is why we didn't test for it in the 
environment.  Also  like  FIV,  it  takes  a  few weeks for  viraemia  to  develop,  leading us  to 
conclude that these animals were probably infected prior to capture and not in the kennel 
premises. FeLV infection has typically been classified as either regressive or progressive, 
and later also latent infections, but recent advances in molecular techniques have refined the 
spectrum of possible host response categories (Hofmann-Lehmann et al., 2008). Techniques 
like real time and quantitative PCR are used to investigate viral plasma RNA and provirus 
DNA loads  even  in  the  absence  of  antigenaemia,  providing  important  insights  into  the 
pathogenesis of this disease. However, until the clinical relevance of this provirus-positive 
status  is  clarified,  the  recommended  procedure  is  still  to  test  for  viraemic  carriers,  and 
remove them.
During the course of this study most of the methods used to assess infection were molecular, 
such as PCR or RT-PCR, and serology was only used for the detection of FIV antibodies and 
FeLV antigen. There is a growing, and in some cases worrying, tendency to forego classical 
virology  techniques  in  favour  of  molecular  techniques.  Both  have  advantages  and 
disadvantages, but it is only when we integrate both approaches that we can truly hope to 
reach new heights of understanding. For example, propagation of viruses in cell cultures is 
still an important step towards understanding pathogenesis and immunologic reactions, and 
an essential step for vaccine production. Serological techniques are only a measure of past 
exposure to a pathogen, but molecular techniques can sometimes detect attenuated viruses 
from  vaccines  which  are  not  indicative  of  natural  infection  or  disease.  In  the  case  of 
coronaviruses, it has been determined that RT-PCR is the best method for diagnostic, since 
the immunity confered by previous infections doesn't last long and vaccination in both dogs 
and cats is still uncommon. The most currently used vaccines for both CDV and CPV/FPV 
are attenuated or modified live vaccines, but according to previous studies, the virus is only 
shed for a few days after vaccination (Kim et al., 2001; McCaw & Hoskins, 2006). Adding to 
that the fact that most of the animals in this study were captured directly from the street, we 
can assume that none of the samples had virus from a live vaccine. The only way to be 
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absolutely sure though, would be to sequence the samples and compare them to the vaccine 
strains.
All the analysed samples were from animals euthanized. One of the euthanasia criteria is the 
likelihood to  be adopted,  so  there is  a  chance that  results  were  biased towards a  high 
prevalence of disease by choosing animals which demonstrated clinical signs of illness. Yet, 
from  the  information  gathered  from  the  animals  clinical  history,  most  were  “apparently 
normal”  on  observation,  and  were  chosen  for  euthanasia  for  their  age  or  aggressive 
behaviour. 
Since most of these animals were strays, one could argue that they should have come in 
contact with these agents during their early life and be immune to infection later on.  This is 
especially true for viruses which provide life-long immunity like CPV/FPV. With other viruses 
like  CDV  and  FCoV,  the  stress  of  capture  could  have  induced  immunosupression  and 
reactivated latent infections. Interestingly, all animals positive to CDV RNA were also infected 
with  CPV  and  three  of  them  with  CCoV,  which  might  explain  viral  reactivation  and 
subsequent excretion. In theses cases, it would be interesting to evaluate the titre of IgM 
antibodies against  CDV and CPV,  to  find  out  if  one of  them was the  result  of  a  recent 
infection.
The concept of One Health recognizes that human, animal and mental health are inextricably 
linked and one aspect of this initiative are the joint efforts to better understand cross-species 
disease transmission, as well as joint cross-species disease surveillance and control efforts 
in public health. The viruses chosen for this study have no proven zoonotic impact, but they 
are nonetheless relevant in this concept, because of their ability to cause terminal illness in 
multiple  species of  animals,  both wild  and domestic,  meaning their  presence and status 
among different wildlife and domestic populations should be assayed. Baseline information 
on potential pathogen exposure is critical for monitoring the population health of threatened 
wildlife species. One of the objectives of this study was to determine whether the stray and 
feral animals in the urban area of Lisbon could act as reservoirs for these different viruses. 
Two particular studies related to domestic animals and their  interaction with wildlife have 
proven that domestic animals represent a disease risk for wildlife. Fiorello et al. (Fiorello, 
Noss & Deem, 2006; Fiorello, Noss, Deem, Maffei & Dubovi 2007) studied the relationship 
between  hunting  dogs  used  in  the  Isoso  region  of  Bolivia  and  the  wildlife  found  in  the 
contiguous Kaa-Iya Del Gran Chaco National Park. They discovered a high seroprevalence 
of CPV and CDV (over 95%) associated with high turnover in the domestic dog population 
and a high number of  opportunities to encounter wildlife on hunting trips in the adjacent 
areas to the national park. Accordingly, several small carnivores sampled directly from the 
area of the national park, showed antibody titers to CDV, CPV and FPV, among others. 
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The effect of these pathogens on naive wildlife populations can have disastrous effects. In 
1999 a suspected canine distemper epidemic killed 95% of  the island fox population on 
Santa  Catalina  Island,  California,  USA  (Timm  et  al.,  2009).  The  comparison  of 
seroprevalences between previous years and the evidence derived by PCR from a recovered 
carcass implicates canine distemper brought by the introduction of mainland raccoons on the 
island as the cause for the population decline.
Canine distemper and its related viruses have caused a number of epidemics around the 
world in the last 20 years. In total, over 50000 harbour seals died in two separate occasions 
around Europe, in 1988 and again in 2002 (Harris, Travis & Harwood, 2008). In both cases 
the virus identified is closely related to CDV and has also been proven to infect terrestrial 
carnivores,  namely  minks  (Blixenkrone-Möller  et  al.,  1992).  The  complex  virus-host 
relationship necessary to cause such an epidemic is far from being completely understood. 
Another two examples have been studied in lions in Africa where two different populations, 
the  Serengeti  lions  in  1994  and  the  Ngorongoro  Crater  lions  in  2001,  suffered  severe 
mortality caused by CDV. Further serological  analyses indicated that  at  least  five “silent” 
distemper epidemics swept through the same two lion populations between 1976 and 2006 
without causing clinical signs or increased mortality. Munson et al. (2008) related data from 
clinical  and pathological  findings,  as well  as climate information,  to  determine that  these 
epidemics with high mortality happened in years after  extreme droughts,  when herbivore 
numbers  were  lowest  and  hemoparisitism  by  Babesia was  highest  in  both  lions  and 
herbivores. The magnified effects of the climate changes and immunosupression caused by 
coincident CDV infection led to the unprecedented mortality. Craft, Volz, Packer and Meyers 
(2009)  determined  by  modelling  a  contact  network  based  on  detailed  behaviour  and 
movement data that although it is possible for Serengeti lions to sustain epidemics of CDV 
and similar  infectious  diseases,  the  1994 epidemic  was caused by  spillovers  from other 
carnivore species, such as jackals and hyenas.
Recently, the discovery of canine distemper in free-ranging felids in Brazil  has also been 
linked with the presence of domestic dogs in the same area (Nava et al., 2009). All of the 
domestic dogs sampled in the Ivinhema State Park in Mato Grosso do Sul,  Brazil,  were 
seropositive to CDV and 60% of the total jaguar population at that park also had antibody 
titers to CDV. These results provide evidence of a spillover effect at the state park as the 
jaguar  territories  seasonally  overlap  with  the  nearby  cattle  grazing  lands  and  provide 
opportunities for interaction between the two species.  The finding leads once again to the 
eminent need for systematic health monitoring of wild carnivore populations and associated 
domestic carnivores.
Goldstein, Mazet and Gill (2009) have also recently found evidence of the introduction of 
phocine  distemper  in  Northern  Sea  Otters  in  the  Pacific  Ocean  close  to  Alaska,  USA. 
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Sequence analysis from samples recovered between 2005 and 2008 has shown that the viral 
fragments amplified were identical to the isolates from the European epidemic of 2002.  The 
authors propose that the sea ice reduction may have resulted in contact between Atlantic, 
Arctic and Pacific Ocean species which was not possible prior to the 2002 epidemic and 
additional studies are needed to determine whether PDV has played a role in the reduction of 
the sea otter population and what risk it represents to other susceptible species in the Pacific 
Ocean.
In Germany,  Frölich et  al.  (2000) collected sera and tissues of  hundreds of  free-ranging 
carnivores such as foxes, martens and minks in order to compare the seroprevalence of 
CDV in different areas. They concluded that there was a significant difference in numbers of 
seropositive foxes between urban, suburban and rural areas, with a greater number in urban 
areas. Assuming a positive correlation between human population density and the density of 
domestic dogs this is another evidence for the association between contact with domestic 
animals and a higher number of seropositive reactors. A similar  study was conducted by 
Riley, Foley and Chomel (2004) where grey foxes in two different areas of Golden Gate 
National Recreation Area, in California, USA, were radio-tracked and tested for the presence 
of antibodies to CPV. The seroprevalence to CPV was higher in foxes in the urban area (63% 
versus 21% in the rural area) and the only seropositive foxes in the rural area were radio-
located in a town on the border of this zone.
In Africa several different species have been identified as susceptible to infection by these 
viruses. Free-ranging jackals in Kenya were found to be seropositive to CPV (34%) and CDV 
(9%) by Alexander,  Kat,  Wayne & Fuller  (1994).  In the same year,  Alexander and Appel 
(1994) published findings of a CDV epizootic in domestic dogs near the Masai Mara National 
Reserve, Kenya which they believed led to the disappearance of at least two packs of African 
wild dogs inside the reserve. They based this decision on the fact that the seroprevalence of 
CDV in domestic dogs rose substantially between 1990 and 1991 (from 1% to 76%), while all 
African wild dogs, which were seronegative between 1989 and 1990, disappeared by the 
beginning of 1991. While no carcasses were recovered which could help ascertain a causal 
relationship  between  the  CDV  epizootic  and  the  decline  in  wild  dog  population,  the 
importance of monitoring populations of domestic animals which are in close contact with 
endangered species was established. In 2008, retrospective data collected by Alexander et 
al. from over a thousand animals went on to identify widespread exposure to a number of 
multi-host canine and feline pathogens among domestic dogs and free-ranging predators in 
four countries across both protected and unprotected areas in southern Africa. Wild dogs 
showed evidence of exposure to CDV, CPV, CCoV, among other viruses, with CPV having 
the lowest prevalence. Lions also showed evidence of widespread exposure to CDV, FPV, 
FCoV  and  FIV,  among  others,  and  the  highest  prevalence  was  for  feline  herpesvirus, 
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followed by FIV. While in this study spotted hyenas were found to be seropositive only to 
CDV  (24%),  Harrison  et  al.  (2004)  discovered  antibodies  to  CDV  (47%),  FIV  (35%), 
FPV/CPV (81%) and FCoV (72%) in the population of the Masai Mara National reserve. 
Besides rabies, CDV was found to be probably the most important pathogen affecting large 
predator populations in southern Africa, in spite of the fact that seropositive animals were 
found in areas isolated from domestic animals. This led to the conclusion that all susceptible 
species populations together could constitute a maintenance community irrespective of the 
size of a particular species component. In this scenario, even small and low density domestic 
dog populations could provide the pathogen flow to allow invasion into a diverse community 
of susceptible hosts which together reach the critical community size required for pathogen 
invasion  and  onward  transmission.  Further  research  is  needed  to  better  understand  the 
potential role of host population structure on divergent patterns of mortality seen with CDV 
outbreaks  in  predator  populations  in  Africa,  possibly  explaining  why  the  lion  population 
seems to have remained remarkably stable during the past 25 years, while others did not.
Outside of Africa, several surveys have focused on these viruses in wildlife, especially in 
felids. In Brazil, Filoni et al. reported in 2006 the first infection of free-ranging felids by FPV. 
Sera from pumas, ocelots and spotted cats were were tested for the presence of antibodies 
to FPV, FeLV, FCoV and FIV, with respective prevalences of 48%, 10%, 5% and 5%. On 
Mauna Kea, in Hawaii, feral cats responsible for the decline of other endangered species, 
specially  birds,  were  shown to be FIV antibody positive  (9%) and FeLV antigen positive 
(16%) (Danner, Goltz, Hess & Banko, 2007).  In Taiwan and Vietnam, endangered species 
such  as  the  leopard  cat  and  the  Formosan  gem-faced  civet  were  shown  to  have  high 
antibody titers to FPV and in spite of this it was possible to isolate the virus from peripheral 
blood mononuclear cells indicating the possibility of a persistent infection with FPV in feral 
cats  in  Asia (Ikeda et  al.,  1999).  In Florida,  USA,  Brown et  al.  (2008)  characterized the 
emergence of FeLV in a previously naïve, and intensively monitored, endangered Florida 
panther population, concluding from retrospective data and phylogenetic analysis that the 
virus was probably introduced from a single domestic cat in 2001, leading to the death of 5 
adult animals until 2005.
Closer to our home, in the Iberian Peninsula, the main environmental concerns regarding 
endangered wildlife  are  the  Iberian lynx,  which  is  considered the most  endangered felid 
species in the world, and the Iberian wolf. There is evidence of widespread exposure of wild 
carnivores  to  CDV  and  CPV  throughout  Europe.  Damien  et  al.  (2002)  identified  a 
seroprevalence of 13% in red foxes in Luxembourg and Sobrino, Arnal, Luco and Gortázar 
(2008) sampled wolves and foxes in Spain and concluded that CPV infection was endemic in 
the wolf population, with a seroprevalence of 62.2% compared to 5.1% in foxes. The total 
CDV  seroprevalence  was  18.7%.  In  Portugal,  an  unprecedented  high  prevalence  of 
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antibodies to CPV was recorded in gennets (94.4%) by Santos, Almendra & Tavares (2009), 
along with seroprevalences to CDV and CPV in wolf (11.1% and 32.1%) and red fox (9.1% 
and  14.3%)  similar  to  previously  reported.  Leutenegger  et  al.  (1999)  identified  high 
prevalences of FeLV (75%) in the European wildcat, which shares the same habitat as the 
lynx, and in Spain, similar prevalences (77%) were reported by Millán and Rodríguez (2009). 
Subsequent studies have identified cases of FeLV in Iberian lynxes and identified this as well 
as other pathogens as important threats to the survival of this critically endangered species. 
Meli  et  al.  (2009)  reported  the  prevalence  of  FeLV,  FPV,  FCoV  and  CDV  in  the  lynx 
population of the Doñana area as 28.9%, 29.5%, 15.9% and 25%, and one dead animal 
presented high viral loads of CDV, indicating that the disease may also represent a threat to 
this species. The authors recommended the implementation of a vaccination program of both 
lynxes and domestic cats and perhaps even dogs in and around lynx's habitats in order to 
keep the infectious pressure of these pathogens as low as possible. Recently there have 
been disease cases of  CDV confirmed in  lynxes and bobcats in North America (Daoust, 
McBurney, Godson, van de Bildt & Osterhaus, 2009)
Unfortunately, the lack of information regarding the health status of the animals sampled from 
the municipal shelter, as well as previous location or possible contacts with wild populations 
living in and around the Lisbon urban area makes it impossible to draw any conclusion about 
the role of these animals in spread and maintenance of common canine and feline viruses. 
An initial testing for infectious agents or a proper quarantine would be advisable to determine 
which animals are infected at the time of arrival in the municipal kennel.
While the animals in this survey were sampled from an area where there is little concern for 
environmental issues like disease spillover, the information from these examples show the 
importance of monitoring the health status of domestic animals which may come in contact 
with  wild  populations,  specially  endangered  species,  such  as  the  Iberian  lynx  and  wolf. 
There is a need for surveillance of stray and feral cats and dogs in areas further to the North 
of Portugal, where the Iberian wolf has its habitat, and around the Reserva da Malcata and 
the Algarve, where the Iberian lynx will be reintroduced in Portugal. The municipal kennels in 
these areas would be good candidates for these surveillance actions.
At the risk of straying from the objectives proposed at the beginning of this study, and leaving 
the  field  of  virology  for  a  moment,  it  is  this  author's  belief  that  there  are  important 
observations  to be made regarding animal  shelters  and their  role  in  our  society.  Animal 
shelters, and especially municipal kennels have gone from a place where unowned pets, 
rounded up from the streets for bounty, were deposited to be clubbed or drown to death, to 
the second main source of adoption for dogs (Zawistowski, Morris, Salman & Ruch-Gallie, 
1998; Scarlett, 2008). Ironically, 90% of a surveyed population in Italy  identifies free roaming 
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dogs and cats  as a problem and cite  personal  safety  and animal  welfare as their  main 
concern (Slater et al., 2008). However, we do seem to be taking new steps every day in our 
quest to regard animals, especially companion animals, as our equals. The Five Freedoms 
are a reflection of this, but we must also understand that the notion of animal welfare is 
different depending on our cultural background (Houpt et al., 2007). The issue is complicated 
and the municipal kennels are in the thick of it, but one thing researchers worldwide agree on 
is  the  need  to  collect  more  information,  and  better,  regarding  pet  population  and  its 
dynamics. This lack of information became known in the early 1990s as Rowan's “statistical 
black hole”,  based on papers by  Dr  Andrew Rowan,  who questioned the expenditure of 
millions of dollars without data to address even the basic questions of this issue (Scarlett, 
2008). While there are still no definitive answers regarding basic issues like the number of 
pets owned and abandoned, other questions are being resolved. The American Society for 
the Prevention of Cruelty to Animals (ASPCA) managed the New York municipal kennel for a 
hundred years, until 1994, and was the first to report a drastic reduction in the number of 
euthanasias per human population after the introduction of a spay-neuter program in 1972 
(Zawistowski et al., 1998). In Taiwan, a recent survey suggested that preventing owners with 
a history  of  unsuccessful  dog ownership  from acquiring dogs was predicted to yield  the 
largest reduction of risk of unsuccessful dog ownership, and that >30% of dog owners felt a 
male  dog  would  feel  shame after  being  neutered  (Weng,  Kass,  Hart  &  Chomel,  2006). 
Several surveys have reported that behavioural problems are one of the main causes of 
abandonment and euthanasia, and cost and lack of proper counseling are issues preventing 
owners from having animals neutered (Houpt et al., 2007; Scarlett, 2008). Sterilization has 
proven to be more useful than euthanasia in the control of pet population, but Natoli et al. 
(2006) proved that >10 years after the implementation of a “no-kill” policy in Rome, Italy, the 
success of TNR programmes depend on education of the population to stop abandonment 
and control reproduction of owned cats in order to achieve control of feral-cat population. In 
Barcelona, management of the municipal kennel by an animal protection organization which 
discontinued the routine use of euthanasia was actually followed by a drastic increase in 
abandonment rates in the region, and unwillingness to perform euthanasia caused CDV to 
become endemic at the kennel (García-Rodríguez et al. 2008). As we can see, a difficult 
balance has to be maintained and we must not forget that the welfare of dogs and cats 
cannot be considered separately from the human social and cultural contexts in which they 
live. There are suggestions of a reduction in number of euthanasias, which cannot be proven 
scientifically  and  counseling  at  the  time  of  adoption  is  essential  to  make  a  difference 
(Scarlett, 2008). 
The situation in Portugal is quite similar to what has been described, and there are estimates 
of 1.9 million dogs and 1.5 million cats in the country, but no official statistics to support it. 
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News reports claim an increase in abandonment rates since 2006, which some speculate is 
related to the economical situation, but a lot more data is needed on pet population and 
municipal kennels to help determine the global picture and trends. Epidemiological surveys 
are an important tool in this aspect, and should help estimate the number of shelters/kennels, 
reasons  for  abandonment  and  euthanasia,  as  well  as  identify  high-risk  populations  for 
unsuccessful  pet  ownership.  More  effort  should  be  spent  on  educating  Portuguese  pet 
owners and caretakers than on capturing feral cats, with the sole purpose of euthanasia. 
International committees, like the European Advisory Board on Cat Diseases (ABCD), the 
American  Association  of  Feline  Practitioners,  and  the  World  Small  Animal  Veterinary 
Association (WSAVA) have established specific guidelines for the management of infectious 
diseases in shelter environment.  Special  attention should be paid to separate housing of 
untested animals and vaccination of cats against FPV and dogs against CPV and CDV.
With the rapid accumulation of  new data comes the task of  disseminating results to  the 
appropriate people, explaining their  strengths and limitations, and assisting policy makers 
translate appropriate results into reasonable policy. The term “consequential epidemiology” 
has been used to describe applied research that has the potential to improve public health 
policy  (Scarlett,  2008),  but  some question  whether  this  task should fall  on the hands of 
veterinary epidemiologists. In the relatively small circle of people interested in pet issues, if 
epidemiologists do not assist in interpretation of the results of their studies, it is questionable 
who can.
For every question answered during our study, more were raised. There is still work to be 
done involving  the  samples  already collected,  but  further  studies  would  also  require  the 
collection of new samples from more specimens. Hopefully the previous discussion was able 
to  underline  the  importance of  phylogenetic  analysis  in  a  world  of  growing viral  genetic 
diversity.  Further  characterisation  of  CDV  samples  could  be  attempted  by  hemi-nested 
multiplex PCR designed to genotype the five major CDV lineages, differentiated by specific 
primers targeted to the H gene (Martella  et  al.,  2007).  Initial  work had begun using this 
method, but was unsuccessful and more time would be needed to adapt the assay to our 
laboratory and samples.  Another  possibility  would be to sequence the complete H gene, 
providing more in-depth knowledge of the characteristics of CDV isolates from the kennel.
The epidemiology of parvoviruses in Europe is slowly beginning to form a picture showing 
different geographical clustering of samples from different countries, and even different cities 
within the same countries. The presence of CPV-2c has already been reported in Portugal, 
but it would be interesting to take advantage of the large number of positive samples from 
the  municipal  kennel  to  learn  more  about  the  evolution  of  this  virus.  The  heavily 
contaminated environment combined with the high density of cats and dogs creates chances 
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for cross-species infection, and even recombination between the two host-range variants has 
been reported (Ohshima & Mochizuki, 2009). The amplification of the full VP2 gene by PCR 
followed by sequencing would be needed to perform further analysis.
Much of  the  same is  true  for  coronavirus  infections  in  both  dogs  and cats.  The kennel 
environment is conducive to recombination events, as seen by the prevalence of co-infection 
with both FCoV types.  Further  genotyping and sequencing of  the kennel  samples would 
allow us to differentiate between true feline or canine viruses and their recombinants, and 
provide  information  on  their  evolution  and  how  frequently  these  events  occur.  Another 
possibility would be to test dogs for CRCoV, as the prevalence for this recently identified 
agent hasn't been reported in the Iberian Peninsula yet.
The information gathered from this study will hopefully pave the way for future collaborations 
with the municipal kennel in Lisbon and other areas. One of the most important points to 
consider in future collaborations would be the possibility of sampling live animals, in order to 
evaluate health status upon entry at the kennel and possibly correlate test results with clinical 
signs observed.
There is a lot of useful information to be gathered from surveys like this, not only regarding 
virological data, but also epidemiology and animal welfare. Of paramount importance is also 
the  information  that  can  be  gathered  at  kennels  and  shelters  about   the  reasons  for 
relinquishing and abandoning pet animals, which will help prevent unnecessary culling and 
lead us to a better understanding and relationship with our four-footed friends.
The municipal kennel of Lisbon is a fertile ground for a variety of different viruses at the 
moment. Our main priority should be to control and eradicate these agents, where possible, 
but in the process we should take advantage of this unique environment to better study the 
interaction between viruses, or virus strains, and their hosts. The results found on this study, 
particularly on parvovirus and FCoV brought to our attention the need for a continued and 
more precise evaluation of the health status of free-roaming stray or feral animals in the 
municipal kennel, to correctly evaluate their role as viral reservoirs within and without the 
kennel premises. The high prevalence of coronavirus infection found in both dogs and cats in 
the Lisbon Municipal  Kennel allowed some viral  genetic characterization,  showing a high 
genetic diversity exemplified by the rate of co-infection with both genotypes of FCoV and 
presence of both types of CCoV. However, the implications of this high exposure to a virus 
with the ability  to  recombine and jump hosts  easily  is  yet  to  be determined and further 
investigation is needed in order to maintain a molecular epidemiological  surveillance and 
help identify further CoV strains, as well as understand the pathogenic potential of  these 
viruses.
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Outside of urban areas this information is also important for wildlife conservation, specially in 
the case of  the critically  endangered Iberian lynx and its  reintroduction project.  It  is  this 
author's opinion that besides typical feline viruses, CDV will also become a very important 
pathogen to monitor for in carnivores sharing the same habitat as the lynx.
In conclusion, our work is just beginning and a lot more research is needed to improve our 
knowledge of  the dynamics of  pet  and stray population and how they interact  with  their 
viruses both in and out of our homes and animal shelters.  Our ultimate goal should be to 
uphold the principles set out by the One Health Initiative, seeking to prevent epidemic and 
epizootic diseases, while maintaining the integrity of ecosystems, for the benefit of mankind, 
domestic animals and biodiversity.
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